Podcasts about CGM

In this episode of Intermittent Fasting Stories, Gin to Richard Flores from Abilene, TX.Join Gin in the new Fast Feast Repeat app for The Grown-Up Year: 52 Weeks to Listen, Play, and Nourish, as well as a growing collection of intermittent fasting resources. Go to app.fastfeastrepeat.com to join us or go to the App Store and download the Fast Feast Repeat app, available for both iPhone and Android.Are you ready to take your intermittent fasting lifestyle to the next level? There's nothing better than community to help with that. In the Delay, Don't Deny community we all embrace the clean fast, and there's just the right support for you as you live your intermittent fasting lifestyle. You can connect directly with Gin in the Ask Gin group, and she will answer all of your questions personally. If you're new to intermittent fasting or recommitting to the IF lifestyle, join the 28-Day FAST Start group. After your fast start, join us for support in The 1st Year group. Need tips for long term maintenance? We have a place for that! There are many more useful spaces beyond these, and you can interact in as many as you like. Visit ginstephens.com/community to join us. An annual membership costs just over a dollar a week when you do the math. If you aren't ready to fully commit for a year, join for a month and you can cancel at any time. If you know you'll want to stay forever, we also have a lifetime membership option available. IF is free. You don't need to join our community to fast. But if you're looking for support from a community of like-minded IFers, we are here for you at ginstephens.com/community. Richard is an architect. He shares how a Christmas trip and a growing awareness of his health concerns pushed him to make a change at the start of 2024. What began as a few days of fasting in solidarity with his daughter's medical prep eventually led him to Gin Stephens' books, then into intermittent fasting. He began on Labor Day of 2024 with the 28-day Fast Start Day by Day book. He explains that the early days were hard, but having a day-by-day roadmap helped him stay committed when his old habits and fears about hunger tried to pull him back.As Richard kept going, he lost weight, moved through plateaus, and started uncovering the deeper reasons he had used food for comfort, celebration, and convenience. He talks openly about a lifelong pattern of oversized portions, family food traditions, and the mental tug of wanting to “finish what's on the plate,” and how fasting has helped him break that cycle. A CGM also gave him a powerful wake-up call, showing him how certain breads, buns, and sugary drinks spiked his glucose and left him crashing, while simpler meals with protein and vegetables kept him satisfied much longer.Richard's story becomes especially encouraging in the way fasting has changed how he lives, not just how he eats. He's stronger, walking more, running in short bursts again, and even planning hikes and more joyful movement like dancing, because he wants fitness to feel fun rather than punishing. He closes with the advice that new intermittent fasters should jump in and start now, because waiting for the “perfect” time only delays the change they want.Join Gin in the new Fast Feast Repeat app for The Grown-Up Year: 52 Weeks to Listen, Play, and Nourish, as well as a growing collection of intermittent fasting resources. Go to app.fastfeastrepeat.com to join us or go to the App Store and download the Fast Feast Repeat app, available for both iPhone and Android.Get Gin's books at: https://www.ginstephens.com/get-the-books.html. Good news! The second edition of Delay, Don't Deny is now available in ebook, paperback, hardback, and audiobook. This is the book that you'll want to start with or share with others, as it is a simple introduction to IF. It's been updated to include the clean fast, an easier to understand and more thorough description of ADF and all of your ADF options, and an all new success stories section. When shopping, make sure to get the second edition, which has a 2024 publication date. The audiobook for the second edition is available now! Join Gin's community! Go to: ginstephens.com/communityDo you enjoy Intermittent Fasting Stories? You'll probably also like Gin's other podcast with cohost Sheri Bullock: Fast. Feast. Repeat. Intermittent Fasting for Life. Find it wherever you listen to podcasts. Share your intermittent fasting stories with Gin: gin@intermittentfastingstories.comVisit Gin's website at: ginstephens.com Check out Gin's Favorite Things at http://www.ginstephens.com/gins-favorite-things.htmlSubscribe to Gin's YouTube Channel! https://www.youtube.com/channel/UC_frGNiTEoJ88rZOwvuG2CASee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This is a Premium-exclusive episode. Go to the Premium feed to listen. Or subscribe to Premium. Blood glucose is easy to measure, but not always easy to interpret. This Premium-only episode brings together insights from several previous guests to examine blood glucose responses in more detail. We discuss the misuse of clinical thresholds, the difference between OGTT results and free-living CGM data, and whether "flatter" glucose curves are actually better in normoglycemic people. The episode also covers when repeated high glucose excursions may be worth investigating, how sugar intake should be interpreted in context, and why skeletal muscle and exercise play such an important role in glucose regulation. Overall, the aim is to clarify what glucose responses can tell us, what they cannot tell us, and how to avoid pathologizing normal physiology. Links:  Go to episode page Join the Sigma newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course

Career exploration often starts with enthusiasm but stalls at the exact point where clarity is supposed to take shape.In this solo episode, Lisa Marker-Robbins shares a pattern she has observed after helping thousands of families, from those who have no idea where to start to those who believe they're checking all the right boxes: young people rarely get stuck because they lack information.Instead, the biggest roadblock appears when it's time to move beyond assessments and online research into real-world career validation. Lisa explains why this stage feels difficult for teens, college students, and young adults. Using a personal continuous glucose monitor (CGM) experiment as an analogy, she illustrates the difference between awareness and validation and previews why courage becomes the next essential step in the career development process.In this episode, you'll discover:The hidden challenges that emerge after an initial career interest takes shapeWhy career confidence is built differently than most families expectThe role discomfort plays in major life and career decisionsHow parents can better interpret periods of stalled progressKey Takeaways: Whether families are just beginning the career conversation or feel they're doing everything right, the validation stage is where many students and young adults lose momentum.A student's willingness to complete assessments and research careers is often evidence of engagement, which means stalled progress is more likely tied to discomfort with the next step than a lack of motivation.Real career confidence is built through validation experiences such as informational conversations, job shadows, internships, part-time work, and other forms of firsthand exposure that test assumptions against reality.Awareness comes from gathering information, but confidence grows when ideas are tested in real-world situations and assumptions are replaced with firsthand experience. “If you skip steps, you skip results, and that's where things fall apart.” – Lisa Marker-RobbinsGet Lisa's Free on-demand video: THE CAREER IDENTIFICATION COMPASS: How To Be Certain Your 15 To 25 Year Old is On The Right Path to Launch With Confidence–Not Confusion: flourishcoachingco.com/video  Connect with Lisa:Website: https://www.flourishcoachingco.com/YouTube: https://www.youtube.com/@flourishcoachingcoFacebook: https://www.facebook.com/flourishcoachingco/ Instagram: https://www.instagram.com/flourishcoachingco/LinkedIn: https://www.linkedin.com/company/flourish-coaching-co

"Making the effort earlier totally changes the trajectory for the rest of your life,” says Jeremy London, MD. London is a board-certified cardiovascular surgeon with more than 25 years of clinical experience caring for patients across the full spectrum of heart disease — from prevention to advanced intervention. Dr. London received his medical degree from the Medical College of Georgia and completed his general surgery residency at Joseph's Hospital in Denver, Colorado. He completed a general vascular and thoracic surgical fellowship at the Carolinas Medical Center in Charlotte, N.C. To deepen his understanding of medicine, he completed the Institute of Functional Medicine core program. 00:00 - When a cardiac surgeon has a heart attack 10:46 - Waking up with different priorities 13:49 - Missed signals 18:35 - The CGM experiment that revealed pre-diabetes 21:43 - The 5 tests that actually matter 25:44 - Diving into Lp(a) 30:36 - Target numbers for primary prevention 32:26 - Why taking medication isn't failure 38:24 - Atherosclerosis starts in childhood 41:19 - Why a zero calcium score doesn't mean you're safe 45:40 - What we don't know 48:41 - GLP-1s & the future of prevention For more about London, visit his website: https://drjeremylondon.com/  We hope you enjoy this episode, and feel free to watch the full video on YouTube! Whether it's an article or podcast, we want to know what we can do to help here at mindbodygreen. Let us know at: podcast@mindbodygreen.com. Learn more about your ad choices. Visit megaphone.fm/adchoices

Send us Fan MailHello and welcome to CGM Presents: In the Word. My name is Dr. Stephanie Wright. On behalf of Charles George Missions, welcome to “Spiritual Warfare Scriptures.” The resource for this series is the Word of God—the Bible—and the book “Spiritual Warfare Manual: ABC to PhD,” written by yours truly.Today's spiritual warfare scripture is about trust. Proverbs 3:5-6 reads:"Trust in the LORD with all your heart; And lean not to your own understanding. In all your ways acknowledge him, And he shall direct your paths.”Trust is a spiritual warfare weapon because we have to trust God in our spiritual battles. Compare this in the natural to the military soldier who trusts his commanders and fellow soldiers in war.One example of spiritual and military warfare is the experience of Dr. Charles Wright, as recounted on pages 60-61 of Spiritual Warfare Manual: ABC to PhD.Reading by CharlesThank you for joining us today.Now, let's turn to Dr. Charles Wright, who will tell you how you may reach us and comment on this podcast.Until next time.If you want to contact us or comment on this podcast, please visit our website and select www.cgmissions.com/podcasts, where all episodes are available by category in series format. You can see some video and audio podcasts at: www.youtube.com/@cgmissionsinc then select from the video or podcast"Playlist."   CGM is a 501(c)(3) nonprofit. Donations may be made on our website:https://www.cgmissions.com/donate-here-general-and-wecare/

Emily spent months farming in Tennessee, attributing her extreme thirst to an electrolyte imbalance. Today, she shares her grounded, "roll with it" approach to managing Type 1 diabetes. Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED  or call 888-721-1514 ABLEnow save for today's needs or invest for tomorrow Tandem Mobi  Eversense CGM Medtronic Diabetes Touched By Type 1 Take the T1DExchange survey Type 1 Diabetes Pro Tips - THE PODCAST Use code JUICEBOX to save 40% at Cozy Earth  Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! * Omnipod Wilmot E, et al. Presented at: ATTD; March 19-22, 2025; Amsterdam, NL. A 13-week randomized, parallel-group clinical trial conducted among 188 participants (age 4-70) with type 1 diabetes in France, Belgium, and the U.K., comparing the safety and effectiveness of the Omnipod 5 System versus multiple daily injections with CGM. Among all paid Omnipod 5 G6G7 Pods Commercial and Medicare claims in 2024. Actual co-pay amount depends on patient's health plan and coverage, they may be higher or lower than the advertised amount. Source IQVIA OPC Library. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!  

This episode breaks down gestational diabetes (new insulin resistance in pregnancy—not type 1 or 2), how insulin and glucose work, and why pregnancy naturally raises insulin resistance (but sometimes the pancreas can't keep up). It covers who's at higher risk (higher BMI, inactivity, prior GDM, certain ethnic groups, prior 9+ lb baby, PCOS, hypertension, heart disease) and how screening works at 24–28 weeks: the non-fasting 1-hour 50g test, followed by a fasting 3-hour 100g test if you “fail” (two elevated values = diagnosis). It explains why the test is a glucose “stress test,” alternatives like at-home fingersticks or CGM, and drink options (Glucola, Fresh Test, jelly beans). Finally, it outlines risks (C-section, shoulder dystocia, preeclampsia, baby hypoglycemia) and care differences between diet-controlled (deliver by 40+6) vs medication-controlled (NSTs/ultrasounds ~32 weeks, deliver ~39).00:00 Gestational Diabetes Overview00:52 How Insulin Works02:31 Risk Factors Explained03:20 Glucose Test Basics05:43 One Hour vs Three Hour07:06 At Home Monitoring Options09:42 Drink Alternatives13:52 Why It Matters Risks18:46 How Care Changes21:27 Final Recap Next Steps24:24 Closing Resources————

When mutual friends in the diabetes community kept telling Rob he had a doppelganger in LA, he figured they were exaggerating. Then he met Dylan Leonard — creative director, documentary filmmaker, college basketball player, type one diabetic, philosophy reader, world traveler — and yeah, the comparisons held up pretty well. Dylan was diagnosed at 15, having dropped 45 pounds before anyone realized something was wrong. He went from a hospital bed thinking he'd never eat sugar again to playing college basketball while managing T1D without a CGM, without a pump, and without knowing a single other person with diabetes for his first decade. What carried him through was activity — six hours of workouts a day during basketball season — and a mindset he's been intentionally building ever since through reading, travel, and genuinely hard conversations with himself. This episode goes wide. Rob and Dylan dig into Dylan's upcoming documentary Breaking Limits: Life on the Edge, which follows elite athletes with type one diabetes across seven different sports — from Olympic competitors to IndyCar drivers to American Ninja Warriors. Dylan invested his own money and thousands of hours into this project, not to make a cent, but to hand a 15-year-old sitting in a hospital bed the resource he never had. They also get into the philosophy of travel as the cheapest education on earth, why our brains literally haven't caught up to the abundance of modern life, the difference between manifesting and obsessing, and what a five-hour train conversation with a Norwegian stranger taught Dylan about human connection. Oh, and they're making plans to run a hoop session next time Rob's in LA. Cameras included. Chapters: 00:00 Rob's T1D doppelganger, meet Dylan 01:49 Dylan introduces himself: creative, hooper, T1D 02:39 Dylan's diagnosis story: 45 lbs lost at 15 04:36 First pickup game post-diagnosis, flying blind 06:26 How activity literally saved his diabetes management 07:28 Life after college ball: blood sugars out of whack 09:12 Morning routine: walk, no phone, delayed caffeine 10:34 Civilized to Death and the myth of progress 14:48 Our brains weren't built for this level of abundance 17:21 Phones, phones everywhere — even for T1D management 19:45 Abundance mindset, FOMO, and the creative career trap 21:01 Why athletes list it: delayed gratification is a superpower 24:20 Self-help books, repetition, and finding what actually works2 7:48 Manifestation is obsession with action behind it 29:15 Compounding growth: who were we six years ago? 33:14 Breaking Limits documentary: T1D athletes across seven sports 38:59 Nine months of travel: Vietnam, Norway, Australia, Mexico 40:00 "The cheapest education on earth is a one-way flight" 44:44 Japan and what loneliness taught him about human connection Resources: * Dylan Leonard on Instagram * Civilized to Death by Christopher Ryan — the book Dylan cites on the myth of perpetual progress and why foraging societies may have been happier than ours * The Game of Life and How to Play It by Florence Scovel Shinn — Dylan's twice-a-year read, ~95 pages, written 100 years ago, still hitting * Risley Health / Rising Above T1D — where Dylan has previously appeared on podcast and debuted early cuts of Breaking Limits (link to Riseley Health podcast)

It's In The News - a look at the top diabetes stories and headlines happening now!   Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcript: fall Detroit and Seattle.   Okay.. our top story this week: XX The FDA approved Tzield for use in stage 3 T1D – that's what we used to just call type 1. It's the stage where the body can no longer produce enough insulin on its own to manage blood sugars you need to start insulin. This approval is for kids ages 8-17 within 8 weeks of a stage 3 T1D diagnosis. It comes after the PROTECT trial and it's the first approval of a disease-modifying therapy for stage 3 T1D. https://www.prnewswire.com/news-releases/breakthrough-t1d-celebrates-approval-of-tzield-for-use-in-stage-3-type-1-diabetes-in-the-us-302799532.html XX Encouraging results from a small study of islet cell transplantation in people with type 1 where now all 12 participants in the trial are currently living without external insulin after receiving transplanted insulin-producing islet cells.   The study, led by researchers at the University of Chicago, tested an experimental immune therapy called tegoprubart Te-GO-Proo-Bart. The drug is designed to prevent the body from rejecting transplanted cells while avoiding some of the side effects associated with standard anti-rejection medications. You've probably heard about this as the Eledon study – many of the participants have been very active on social media. It was presented at ADA. transplants.https://www.breakthrought1d.org/news-and-updates/tegoprubart-islet-transplant-all-participants-off-external-insulin/ XX New data suggest that acmopatide (ack-MOW-puh-tyd) (CT-868), an experimental once-daily dual GLP-1/GIP receptor agonist, may help people with type 1 diabetes improve blood sugar control, lose weight, and reduce insulin use. Across all doses, participants lost up to 7% of their body weight and reduced insulin use by as much as 15%. The study lasted just 16 weeks, so researchers say longer-term data will be needed to determine whether the benefits can be maintained and whether lower insulin requirements can be achieved without increasing the risk of hypoglycemia. XX A new combination therapy that pairs an amylin analog with semaglutide improved both blood sugar levels and weight loss in several groups of people with type 2 diabetes. The once-weekly injectable, known as CagriSema (KAG-ruh-SEM-uh), was evaluated in three Phase 3 REIMAGINE studies. In people early in the course of type 2 diabetes, researchers reported A1C reductions of up to 1.8 percentage points and significant weight loss compared to placebo after 40 weeks of treatment. Investigators also noted improvements in several cardiometabolic risk factors, including blood pressure. https://www.medpagetoday.com/meetingcoverage/ada/121658 XX Stelo for kids is now FDA cleared.. the over the counter Glucose Biosensor System is now approved for children as young as 2 years old who do not use insulin. The FDA identified pediatric prediabetes as a growing public health concern motivating the expanded indication, noting OTC CGMs can help younger users and their caregivers build glycemic awareness, track patterns in response to me https://www.hcplive.com/view/fda-clears-first-otc-glucose-monitor-for-children XX Insulet presented new data from its STRIVE and EVOLUTION 3 studies showing improved glucose control with its next-generation Omnipod 6. That's , the company's upcoming hybrid closed-loop system for people with type 1 and type 2 diabetes. The main difference between the Omnipod 6 and Insulet's current Omnipod 5 patch pumps is that the new system has a lower glucose target of 100 mg/dL and better Bluetooth connectivity Insulet also shared progress on a fully closed-loop system designed specifically for type 2 diabetes. It  does not require carb-counting or insulin bolusing ahead of meals. Physicians also don't need to program the starting settings.   XX Abbott shared new research highlighting challenges in identifying and managing diabetic ketoacidosis (DKA). The studies coincide with the company's development of Libre Duo, a dual glucose-ketone sensor that continuously tracks both measurements. Abbott reported that DKA can be difficult to recognize when patients first arrive at the hospital, based on data from more than 100,000 people. The company has submitted the dual sensor to the FDA and recently received CE Mark approval in Europe. More news from ADA including info from Dexcom, Sequel, Sensonics and the world loses a tireless T1D advocate.. that's all to come right after this. --   Back to the news.. XX   Dexcom announced its acquisition of Nutrisense, a company that combines continuous glucose monitoring with nutrition coaching and behavioral support. At ADA, the company also presented results from the CONNECT study showing significant A1C reductions and improved glucose control in people with type 2 diabetes not using insulin. The findings add to growing evidence supporting CGM use beyond intensive insulin therapy. We did an episode with CEO Jake Leach at ADA about these announcements as well as updates on G8, their hospital product and much more. XX Sequel Med Tech reported positive clinical results evaluating its twiist automated insulin delivery system in people with type 2 diabetes. The study showed improvements in A1C and time in range over 13 weeks XX Senseonics presented new real-world data supporting the performance of its Eversense 365 implantable CGM. The analysis included more than 12,000 sensors and demonstrated sustained accuracy and effectiveness in both open-loop and automated insulin delivery settings. Researchers also evaluated Eversense use with Sequel Med Tech's twiist system. The findings support broader use of long-term implantable CGM technology.   -- MiniMed used ADA 2026 to spotlight two recently cleared diabetes management systems. The MiniMed Flex pump offers a smaller, smartphone-controlled insulin pump option, while MiniMed Go combines the InPen smart insulin pen with Abbott's Instinct sensor. The products received FDA clearance earlier this year. XX Tandem Diabetes Care highlighted data supporting the use of its Control-IQ automated insulin delivery technology during pregnancy. Results from the CIRCUIT trial showed users spent approximately three additional hours per day in the recommended pregnancy glucose range compared with standard therapy. The findings helped support recent regulatory approvals for pregnancy use in both Europe and the United States. Tandem also expanded indications for adults with type 2 diabetes. XX Beta Bionics presented real-world data from the first three years of iLet Bionic Pancreas use. The company reported a 25% improvement in time in range among users, along with positive feedback from clinicians about simplified diabetes management. The iLet system requires only a user's weight to begin therapy and eliminates carbohydrate counting. Beta Bionics also highlighted growing access to near-real-time outcomes through its public data dashboard. XX MannKind presented new findings supporting its Afrezza inhaled insulin at ADA 2026. A post-hoc analysis of the INHALE-1 study found that pediatric users reported greater treatment satisfaction compared with those using rapid-acting injected insulin. The results come shortly after FDA approval expanded Afrezza's indication to include children. We did a bonus episode with one of the lead investigators of the study that lead to that approval. XX Adaptyx presented early clinical data supporting a wearable sensor that continuously measures cortisol levels. The device successfully tracked cortisol changes during both controlled testing and overnight monitoring in first-in-human studies. Company leaders say cortisol plays a major role in conditions including diabetes, hypertension, and depression. The technology uses synthetic DNA-based molecular switches to generate real-time readings.   XX Biolinq shared new clinical findings for its Shine continuous glucose monitoring system. The needle-free device combines glucose monitoring with activity and sleep tracking .The system received FDA clearance in 2025. They're also looking at measuring lactate through the sensor. XX Long-time T1D advocate Kent Schnakenberg died last week. Schnakenberg was known in his community for using his love of bicycling to raise awareness of Type 1 diabetes. He also advocated for improving the lives of those living with the disease. Inspired by his niece, Michelle, who was diagnosed with juvenile diabetes when she was 13 years old, since 2014 he has traveled around the country cycling thousands of miles, speaking to hundreds and hundreds of kids and raising Money. According to Schnakenberg's family, he suffered a head trauma incident in his home on Wednesday. I spoke to Kent years ago – I believe the first year of the podcast. A sad loss but wonderful to see so many tributes and memories posted on social media in the last few days. https://diabetes-connections.com/john-costik-co-creator-of-nightscout-team-schnak/ https://www.wibw.com/2026/06/12/team-schnak-founder-kent-schnakenberg-passes-away/ XX And finally. Alexander Zverev (ts-ver-uhv) won the French Open, his first Grand Slam title. He lives with type 1, he paused a couple of time to check his blood sugar. He was diagnosed at age 4 and partners with Medtronic. "Becoming a professional tennis player was always my dream," Zverev shared in an article posted by Medtronic. "Early on, I was told that competing at the highest level with diabetes was impossible — but my family and I refused to accept that. That's why I'm partnering with Medtronic Diabetes: I want every person with diabetes to feel empowered to live the life they want." He also has a foundation committed to children with type 1 diabetes. Among other things, the life-saving insulin and other essential drugs are provided – also in developing countries." https://www.mensjournal.com/news/alexander-zverev-diabetes-wins-french-open-2026-medical-condition

 Most people with type 1 diabetes are told: “just have a snack before exercise.” But blood sugars are far more complex than that.I ran a real experiment using a CGM—intentionally spiked my glucose, then brought it back down using exercise. The result? Almost exactly where I started.It's not guesswork. It's timing, volume, and understanding how your body responds. >> ENJOY!Join The Tribe: https://thewarriorstribe.comPurchase your copy of "The Blood Sugar Freedom Formula" book TODAY!https://www.amazon.com/dp/1964811880?psc=1&smid=ATVPDKIKX0DER&ref_=chk_typ_quicklook_imgToDpGrab your free ticket to this advanced T1D training here:https://diabetesinaction.comFree T1D Support Group Here: https://diabetesinaction.com/join-group-1---------Welcome to the Pardon My Pancreas podcast!! This show is all about REAL life with type 1 diabetes, understanding fluctuations, and how to stabilize your blood sugar for good. Your host is Matt Vande Vegte is a certified personal trainer, nutritionist, and type 1 diabetic whose biggest goal in life is to help people with diabetes around the world live their lives fearlessly. Looking for an online health coaching program to help you live your best life? Go to https://www.ftfwarrior.com to learn more about his program for diabetics only that is focused on helping you reach your goals while living a happier and healthier life. Join the Tribe today!This podcast is sponsored by FTF Warrior - An online health and fitness coaching company for type 1 diabetics dedicated to helping them master their blood sugars through any activity, exercise, or meal!https://www.ftfwarrior.comFollow Matt here:Instagram: https://www.instagram.com/ftfwarrior/Facebook: https://www.facebook.com/ftfwarrior/YouTube: https://www.youtube.com/c/ftfwarrior------------------------------------------------------Disclaimer: While we share our experiences with diabetes, nothing we discuss should be taken as medical advice. Please consult your doctor or medical professional for your health and diabetes management. 

In this episode of the TCOYD Podcast, Dr. Edelman and Dr. Pettus are joined by pediatric endocrinologist Dr. Jamie Wood, medical director of pediatric diabetes at Rainbow Babies & Children's Hospital and an investigator on the INHALE-1 trial, to talk through inhaled insulin in kids and where it fits in real-world pediatric care.The conversation focuses on the recent approval of Afrezza for children as young as six, and what the INHALE-1 trial actually showed. Dr. Wood walks through the study design, A1C results, lung-function and safety data, and the practical aspects of dosing inhaled insulin in a pediatric population. Rather than positioning it as a replacement for injections or pumps, the discussion centers on finding the right fit for each child's needs, from the newly diagnosed kid with a needle phobia to the teen trying to dose discreetly during a 20-minute school lunch.Dr. E, Dr. P, and Dr. Wood also discuss the everyday realities that shape how this option is used, including the set-dose cartridge sizes, a titration approach refined in clinic, and how families are mixing and matching tools alongside automated insulin delivery. The takeaway is encouraging: there are more options than ever for managing mealtime insulin in kids, and this one may help fill some of the gaps left by injections and pumps.Key Topics • The recent approval of inhaled insulin for children as young as six • How the INHALE-1 pediatric trial was designed • A1C results and what the primary endpoint analysis showed • Continuous glucose monitor (CGM) metrics across the two groups • Lung-function (FEV1) monitoring and pediatric safety • Weight and body mass index (BMI) findings • Why mealtime dosing is a leading unmet need in pediatric type 1 diabetes (T1D) • The set-dose cartridge approach and how it reframes meal sizes • A real-world titration method for inhaled insulin • Managing cough and other practical considerations • Needle phobia and the kids who struggle most with injections • Using inhaled insulin alongside automated insulin delivery (AID) systems • What's coming next, including a smaller cartridge dose and a new-onset trial Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram: / tcoydFacebook: / tcoydStay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

Your body after a baby was never a calorie problem. It is a metabolic one. In this Her Stack episode I am walking you through exactly how to restore your metabolism so body composition follows. The goal is not weight loss. The goal is metabolic restoration. Body comp is downstream. I am breaking down the four drivers that actually run body composition (insulin, thyroid, sleep, growth hormone), the four pillars to address them (nutrition, lifestyle, supplements, peptides), and the exact peptide sequencing for women. Plus my honest take on GLP-1s including semaglutide, tirzepatide, and retatrutide, where they actually fit, and why microdosing makes more sense than chasing the scale. I also share what nobody talks about. Eating less postpartum often makes body composition worse. Breastfeeding is sequencing, not failure. Growth hormone is the layer women never hear about, so they plateau and blame their age when it was a fixable signal the whole time. Join The LongHer Life for women-specific guidance on peptides, hormones, and longevity.   I TALK ABOUT: 00:00 Welcome back to the Her Stack series 00:53 Updates: working with me one-on-one and my new peptide planner 06:15 Why body composition not weight, and why metabolism not calories 07:01 The four drivers and four pillars framework 09:00 Driver 1: Insulin resistance and why stubborn middle fat is an insulin problem, not a calorie problem 11:30 Driver 2: Thyroid, and why TSH alone misses Free T3 (the worker hormone) 14:50 Driver 3: Sleep, cortisol, and the loop back to insulin resistance 19:32 Driver 4: Growth hormone, the layer nobody talks about that's blunted postpartum and through aging 22:19 The labs to actually ask for: fasting insulin, Free T3, IGF-1, DHEA-S, plus a 2-week CGM 24:30 Pillar 1: Nutrition (protein floor of 120g, leucine at every meal, food order, fiber, and why you should NOT under-eat) 28:06 Why leucine flips the muscle-building switch 35:00 Pillar 2: Lifestyle and biohacking (lift 3x a week, walk 7-10k steps, zone 2, cold and heat, red light, and the fringe tier honestly) 45:30 Pillar 3: Supplements (creatine, magnesium glycinate, myo-inositol, omega-3, berberine, and breastfeeding sequencing) 51:01 Berberine, AMPK, and "nature's metformin" 55:30 Pillar 4: The peptide stack starts here with AOD-9604 56:00 AOD-9604, the growth hormone fragment, why I am personally taking it right now 01:02:00 MOTS-c, the "exercise in a molecule" mitochondrial peptide 01:05:00 5-Amino-1MQ and releasing the brake on fat cells 01:07:00 Sermorelin, the gentle GH entry (what a secretagogue actually is) 01:10:00 CJC-1295, Ipamorelin, and Tesamorelin for post-weaning GH restoration 01:13:00 The GLP-1 honest take: semaglutide, tirzepatide, and the retatrutide question 01:14:00 Why retatrutide is called the triple agonist and where it fits (and where it doesn't) 01:19:27 Recap and wrap-up   RESOURCES: Work with me one-on-one on your peptide stack and protocol. The Her Stack Planner, the first peptide tracking journal built around female biology. Free Peptide Masterclass for Women. Join The LongHer Life for women-specific guidance on peptides, hormones, and longevity.   LET'S CONNECT: Instagram, TikTok, Facebook Shop my favorite health products Listen on Spotify, Apple Podcasts, YouTube Music

Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode, shot live at the American Diabetes Association (ADA) Scientific Sessions 2026 in New Orleans, Louisiana, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, discuss the latest major trial results like CONNECT, TRIUMPH, and TRANSCEND.To begin the episode, Isaacs and Bellini, discuss major highlights from ADA Scientific Sessions, focusing first on the landmark CONNECT trial evaluating continuous glucose monitoring (CGM) in people with type 2 diabetes who are not treated with insulin. They reflect on the evolution of CGM technology, from its early use primarily in type 1 diabetes to its expanding role in type 2 diabetes management, and explain why this trial represents an important step forward for patients who have historically had limited access to CGM.The hosts review the randomized controlled trial findings, emphasizing the significant improvements in glycemic outcomes, including a 1.6% reduction in A1c from baseline and an approximately 0.9% greater reduction compared with standard care. They also highlight the increase in time in range, with participants using CGM achieving roughly five additional hours per day in target glucose range. The magnitude of these findings is discussed as a practice-changing development, with the potential to influence future clinical guidelines and strengthen recommendations for CGM use among individuals with type 2 diabetes who are not using insulin.The discussion also explores the broader implications of the CONNECT trial for healthcare access and insurance coverage. The hosts note that randomized controlled trial evidence has historically played a key role in shaping standards of care and payer decisions, and they suggest that these results may help support wider adoption of CGM by demonstrating meaningful improvements in glucose control and patient outcomes.The conversation then shifts to emerging pharmacologic advances, with a focus on retatrutide, a novel triple agonist targeting GLP-1, GIP, and glucagon pathways. The hosts discuss new data showing substantial metabolic benefits in people with type 2 diabetes, including up to 17% weight reduction and nearly 2% A1c lowering. They highlight how these findings represent a major advancement in diabetes and obesity treatment, particularly as clinicians continue to see increasingly powerful effects from next-generation incretin-based therapies.Isaacs and Bellini explore how these therapies may reshape treatment strategies by allowing clinicians to tailor medication choices based on individual patient needs and goals. They discuss the importance of considering both glucose lowering and weight reduction effects, recognizing that some patients may benefit from significant weight loss while others may require a more balanced approach focused primarily on glycemic improvement.The hosts also address important unanswered questions surrounding the use of highly effective weight-loss medications, including appropriate treatment targets, the limitations of BMI as a measure, and the importance of preserving muscle mass and overall function. They emphasize the need to consider body composition, physical activity, resistance training, and patient characteristics—particularly in older adults or those at risk for frailty—when developing long-term treatment plans.The episode concludes with a reflection on the rapidly evolving landscape of diabetes care. The hosts highlight how advances in CGM technology and novel metabolic therapies are creating new opportunities to improve outcomes, personalize treatment approaches, and redefine the future management of people living with diabetes.Editors' Note: Isaacs reports disclosures with Dexcom, Abbott, Lilly, Novo Nordisk, Medtronic, Insulet, and others. Bellini reports disclosures with Abbott Diabetes Care, MannKind, Povention Bio, and others.

Sabrina discusses her vigilant approach to managing her two-year-old son Zevi's Type 1 diabetes. Listen as she navigates diluted insulin, looping, and "vibe bolusing" a toddler. Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED  or call 888-721-1514 ABLEnow save for today's needs or invest for tomorrow Tandem Mobi  Eversense CGM Medtronic Diabetes Touched By Type 1 Take the T1DExchange survey Type 1 Diabetes Pro Tips - THE PODCAST Use code JUICEBOX to save 40% at Cozy Earth  Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! * Omnipod Wilmot E, et al. Presented at: ATTD; March 19-22, 2025; Amsterdam, NL. A 13-week randomized, parallel-group clinical trial conducted among 188 participants (age 4-70) with type 1 diabetes in France, Belgium, and the U.K., comparing the safety and effectiveness of the Omnipod 5 System versus multiple daily injections with CGM. Among all paid Omnipod 5 G6G7 Pods Commercial and Medicare claims in 2024. Actual co-pay amount depends on patient's health plan and coverage, they may be higher or lower than the advertised amount. Source IQVIA OPC Library. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!

Tyler Cook is a professional GT3 racing driver who has competed in some of the most grueling endurance races on the planet, the 24 Hours of Spa, the 24 Hours of Nürburgring, IMSA, and GT World Challenge Europe. He's also been living with type 1 diabetes since he was 11 years old. This episode gets into what it actually looks like to manage blood sugar in a fire suit, in a 130-degree cockpit, at 150 miles per hour, sometimes at 3 a.m. Tyler takes us back to his diagnosis in 2006 — an ICU stay, four IVs, and a very specific grief over the chocolate mousse at Epcot's France pavilion. From there, he walks us through the journey from go-karts in his dad's garage to GT3 race cars with 650 horsepower. Along the way, there was bullying in middle school over his diet, sneaking to the bathroom to give injections on dates, and a decision somewhere along the line to stop hiding his diabetes and start owning it. We get into the technical side, too: how OmniPod changed his race management strategy, why adrenaline sends his blood sugar climbing instead of crashing, what a 24-hour-race insulin plan actually looks like, and what it means to have a Gatorade button wired into your cockpit as an emergency low-blood-sugar protocol. Tyler also talks about the physical training side of racing — heart rate zone work, neck day (yes, neck day), and why a GT3 driver can be pressing 1,200 pounds of brake force per pedal. The episode wraps with something that's been sitting with both Rob and Tyler: the idea of trusting the process. For Tyler, the lesson comes through racing — you can't skip steps from spec Miata to GT3. For people with T1D, it's the same. Wherever you are in your management journey, that's where you are — and it's going to get better if you just keep going. Chapters: 00:00 Climbing out of a race car at 2 a.m. 00:51 Introducing Tyler Cook, GT3 driver with T1D 01:52 Diagnosis at 11: ICU, four IVs, and Epcot chocolate mousse 04:16 Go-karts at three, racing in the family DNA 06:20 Racing pre-CGM: going off vibes and feeling lows 07:29 Bullied for his diet in middle school 09:53 Dating with diabetes and deciding to stop hiding it 12:29 Going public: from fear of losing opportunities to advocacy 13:35 A potential cure and why staying healthy now matters 17:19 What GT3 racing actually is — and why you should go watch it 23:02 The Gatorade button: CGM and cockpit glucose management 24:28 130-degree cockpits, adrenaline spikes, and pre-race hydration 25:39 WHOOP strain scores: practice vs. race stint 28:37 Training for the car: heart rate zones, neck day, 1,200-lb brakes 36:45 What Tyler would tell 11-year-old himself: trust the process Resources: * Tyler Cooke Instagram * Breakthrough T1D * Conor Daly (T1D IndyCar driver Tyler mentioned)

Could hidden blood sugar problems be affecting energy, belly fat, sleep, and long-term health long before a doctor ever warns about them?Many men over 50 pay attention to cholesterol, blood pressure, and annual lab work. Far fewer understand what is happening with their blood sugar throughout the day or how it may be contributing to insulin resistance, weight gain, brain fog, and declining metabolic health.Karen Kennedy, author of the new book, Hack Your Blood Sugar, explains how a continuous glucose monitor can provide real-time feedback that helps men better understand how food, stress, sleep, and exercise affect their bodies. She also shares practical ways to use a CGM device without becoming obsessed with the numbers.What listeners will discover:Why a glucose monitoring device can reveal health patterns that traditional blood tests often missHow simple habits like meal timing and post-dinner walks can help lower blood sugarWhy stress and poor sleep may be driving blood sugar problems even when diet looks healthyListen for a practical framework that can help create more clarity, better decisions, and stronger health after 50.If you find this episode helpful, please subscribe and share it with friends and family.NEW FOR 2026: Click here to get my weekly Unstoppable After 50 Playbook

Send us Fan MailHello and welcome to CGM Presents: In the Word. My name is Dr. Stephanie Wright. On behalf of Charles George Missions, welcome to Season 14, “Spiritual Warfare.” This is episode 10 in our series, entitled “Spiritual Warfare Scriptures.” The resource for this series is the Word of God—the Bible—and the book “Spiritual Warfare Manual: ABC to PhD,” written by yours truly.Sit back, relax, and take a deep breath because today's spiritual warfare scripture is about rest. Matthew 11:28 says, “Come unto me, all ye that labor and are heavy laden, and I will give you rest.” Rest is a spiritual warfare weapon because spiritual warfare is perpetual—never-ending. When you commit your life to Christ, it is a lifetime commitment. There is no discharge from the Lord's army, so you will need to learn to rest in the Lord. Also remember, there is a great reward in serving Him— ETERNAL LIFE, and other bonuses we do not even know about are the compensation we receive. 1 Cor. 2:9 tells us we haven't seen nor heard, nor has our heart known the things God has prepared for us who love him.And consider this. The military soldier takes something called R&R (Rest and Relaxation). The spiritual warfare soldier has to do the same. It may not be a trip to a tropical island, although that would be nice. You may take an afternoon off and do what you please. But take a break and lighten up. Rest is good for your heart and soul. Prov. 17:22 tells us, A merry heart doeth good like a medicine: but a broken spirit drieth the bones.You need to refresh yourself for the next battle.My R&R includes sitting in a comfortable chair, viewing and listening to nature from my window during prayer time. The moment I sit down, I exhale, and I know I am at peace with God.So, take time every day, even if it's only 15 minutes, and rest in the Lord. Rest is another weapon in your spiritual warfare arsenal.Thank you for joining us today.Now, let's turn to Dr. Charles Wright, who will tell you how you may reach us and comment on this podcast.Until next time.If you want to contact us or comment on this podcast, please visit our website and select www.cgmissions.com/podcasts, where all episodes are available by category in series format. You can see some video and audio podcasts at: www.youtube.com/@cgmissionsinc then select from the video or podcast"Playlist."   CGM is a 501(c)(3) nonprofit. Donations may be made on our website:https://www.cgmissions.com/donate-here-general-and-wecare/

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.In this episode, Coach Ken and Graham tackle one of the most fascinating and controversial questions in the diabetes world:What will happen first—a cure for Type 1 diabetes or a way to prevent it altogether?The conversation begins with a discussion around continuous glucose monitors, the barriers to bringing new diabetes technology to market, and why FDA approval plays such a significant role in innovation and accessibility.From there, Ken and Graham zoom out to examine diabetes on a global scale. They explore the challenges people with diabetes face in developing countries, the realities of insulin access, and whether advanced technology like CGMs should be prioritized when many people still struggle to obtain life-saving insulin.The discussion then shifts into the future of Type 1 diabetes research, including Teplizumab (Tzield), immunotherapy, stem cell research, autoimmune triggers, and the ongoing debate between prevention and cure.Along the way, Ken shares his perspective on the role that lifestyle factors—including stress, sleep, nutrition, exercise, and overall health—may play in autoimmune conditions, while Graham challenges the conversation by exploring whether vaccines, immunotherapy, or preventative treatments could eventually become the standard approach.This episode is an honest discussion about innovation, skepticism, hope, and the future of diabetes care.

We're back with Episode 59 and I am running on fumes. We processed four hogs this past weekend — start to finish, ourselves, no abattoir — and walked away with 600 lbs of high quality pork. 17-hour day. Worth every minute. If you eat meat, you owe it to yourself to understand where it comes from and be part of that process at least once. Circle of life, man.Greg and I also catch up on a full week into our new training split. Legs were brutal — 70,000 lbs of volume — and I'm still feeling it. We break down what's working, what we tweaked on chest day, and why I think this split might carry me all the way into prep for Worlds next November.Then we get into the Enhanced Games happening in Las Vegas. No drug testing, no banned substances — just whatever you want to pump into yourself. I get it, I understand why it exists, but it's a slippery slope. We also talk about the 23-year-old Brazilian bodybuilder who just passed away from hypoglycemia linked to exogenous insulin. It's a sobering reminder of where that road can lead.And to top it all off — I'm doing the sardine fast. Five days, 18 cans a day, iso-caloric at 3,000 calories. Got bloodwork done beforehand, CGM and continuous ketone monitor going, and we'll see what actually changes. Tune in next week for the full breakdown.Topics covered:Processing 4 hogs from start to finish on the homesteadCost breakdown: raising your own meat vs. buying retailOne week into the new high-volume training splitDEXA scan planning and comp prep timeline for WorldsThe Enhanced Games — human performance or chemistry contest?The dangers of exogenous insulin in bodybuildingThe sardine fast experiment beginsGreg Mahler is also a lifetime natural bodybuilder, and can be followed on Instagramhttps://www.instagram.com/ketogreg80/Register For My FREE Masterclass: https://www.ketobodybuilding.com/registration-2Get Keto Brick: https://www.ketobrick.com/Subscribe to the podcast: https://open.spotify.com/show/42cjJssghqD01bdWBxRYEg?si=1XYKmPXmR4eKw2O9gGCEuQ

In this episode, Tara breaks down the top five hidden blocks to better body composition—low deep sleep and under‑recovery, poor insulin sensitivity, not enough muscle, overeating "healthy" fats, and the "I come last" mindset—plus practical fixes you can start using right away.   RESOURCES: Learn more about Tara here: http://taragarrison.com Instagram: @coachtaragarrison @higher.coaching Get 10% off Peluva minimalist shoe with coupon code COACHTARA here: http://peluva.com/coachtara   CHAPTERS: 00:00 – Solo intro: 5 biggest body comp blocks 00:45 – Sponsor: Peluva minimalist shoe ad 02:31 – Block #1: Under‑recovery and low deep sleep 07:00 – Fixing deep sleep: stress, nervous system, rituals 12:04 – Sleep environment: cool, dark, quiet room tweaks 13:31 – Night wakings, blood sugar drops, CGM insights 15:37 – Perimenopause, HRT and better sleep 21:40 – Block #2: Insulin resistance and labs that matter 27:33 – Fasting insulin ranges and getting more sensitive 34:23 – Block #3: Not enough muscle mass (why it matters) 41:31 – How to actually build more muscle and recover 41:57 – Block #4: "Eating healthy" but way too much fat 49:28 – Block #5: "I come last" mindset and boundaries 51:51 – Missing piece: fun, joy, play as real health    WORK WITH TARA: Are You Looking for Help on Your Wellness Journey? Here's how Tara can help you: TRY TARA'S APP FOR FREE: http://taragarrison.com/app INDIVIDUAL ONLINE COACHING: https://www.taragarrison.com/work-with-me CHECK OUT HIGHER RETREATS: https://www.taragarrison.com/retreats   SOCIAL MEDIA:  Instagram @coachtaragarrison TikTok @coachtaragarrison Facebook @coachtaragarrison Pinterest @coachtaragarrison   INSIDE OUT HEALTH PODCAST SPECIAL OFFERS: ☑️ Upgraded Formulas Hair Test Kit Special Offer: https://bit.ly/3YdMn4Z ☑️ Upgraded Formulas - Get 15% OFF Everything with Coupon Code INSIDEOUT15: https://upgradedformulas.com/INSIDEOUT15 ☑️ Rep Provisions: Vote for the future of food with your dollar! And enjoy a 15% discount while you're at it with Coupon Code COACHTARA: https://bit.ly/3dD4ZSv

Gillian discusses teenage rebellion, living with necrobiosis lipoidica, and a legal battle against medical school bureaucracy over a false-positive alcohol test caused by high blood sugar fermentation. Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED  or call 888-721-1514 ABLEnow save for today's needs or invest for tomorrow Tandem Mobi  Eversense CGM Medtronic Diabetes Drink AG1.com/Juicebox Touched By Type 1 Take the T1DExchange survey Type 1 Diabetes Pro Tips - THE PODCAST Use code JUICEBOX to save 40% at Cozy Earth  Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! * Omnipod Wilmot E, et al. Presented at: ATTD; March 19-22, 2025; Amsterdam, NL. A 13-week randomized, parallel-group clinical trial conducted among 188 participants (age 4-70) with type 1 diabetes in France, Belgium, and the U.K., comparing the safety and effectiveness of the Omnipod 5 System versus multiple daily injections with CGM. Among all paid Omnipod 5 G6G7 Pods Commercial and Medicare claims in 2024. Actual co-pay amount depends on patient's health plan and coverage, they may be higher or lower than the advertised amount. Source IQVIA OPC Library. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan. 

Send us Fan MailToday's spiritual warfare scripture comes from Isaiah 40:31.“But they that wait upon the Lord shall renew their strength, they shall mount up with wings as eagles, they shall run and not be weary, and they shall walk and not faint.”One of the most powerful weapons in our spiritual warfare arsenal is waiting on God. It is powerful because we do not realize what He is doing in the background for us while we are waiting. But when we are obedient to the Word of God, which tells us to “wait upon the Lord,” we honor Him, and because we honor Him by honoring His Word, He will do for us what Isaiah 40:31 says He will do.I speak based on a recent personal experience I alluded to in the last podcast. It took four years with a situation that was very painful, but in the end, in thecourse of my waiting and being obedient, praying, fasting, and listening to the Holy Spirit — in the end, God showed me all that he was doing in the background while I was waiting on Him to bring success so that I could mount up with wings as an eagle. God moved my enemies out of the way, exposed their lies, and empowered me, emotionally, financially, and most of allspiritually. He is now teaching me to run and not be weary as I fulfill the tasks that came with the victory. God gives us the victory, so that we can walk in it, and not be weary.Again, I waited upon the Lord during this four-year test by continuing in reading and studying His Word, praying with fasting, staying in church, giving financially and personally to the Lord's work—in short, I was obedient to the leading of the Holy Spirit. And, yes, I prayed for my enemies.While we are waiting on him, he will strengthen us, and when the test is finally over, we will see what he has been doing in the background. If you don't see it in this life, maybe He will reveal it to you in the next life—but truthfully, I don't think you will care when you get to heaven.So, wait on the Lord for He shall renew your strength, and you shall mount up with wings as an eagle, you shall run and not be weary, and you shall walk and not faint.If you want to contact us or comment on this podcast, please visit our website and select www.cgmissions.com/podcasts, where all episodes are available by category in series format. You can see some video and audio podcasts at: www.youtube.com/@cgmissionsinc then select from the video or podcast"Playlist."   CGM is a 501(c)(3) nonprofit. Donations may be made on our website:https://www.cgmissions.com/donate-here-general-and-wecare/

Dr. Corey Schuler, PhD(c), FNP, DC, CNS, and director of medical affairs at Allergy Research Group, details his paper “Energy Allocation Resilience and Endocrine Integration” in the International Journal of Molecular Sciences. He introduces the Energy Allocation System (EAS), which emphasizes how the body allocates energy—not just produces it—and links many symptoms to impaired bioenergetics and resilience. They discuss mitochondria as energy generators and cellular signaling hubs, the integrated stress response and endocrine coordination (HPA axis, thyroid, gonads), and mitohormesis/eustress (exercise, fasting, heat/cold, circadian “zeitgebers”). Schuler explains nuanced testing for fatigue (diurnal cortisol, CGM patterns, thyroid markers including T3/reverse T3) and a case of a perimenopausal woman where oral contraceptives and cortisol dysregulation affected glucose patterns. They cover mitochondrial support (removing obstacles like pollutants/antibiotics, triglycerides, carnitine, dietary fats, micronutrients) and pacing/sequencing lifestyle interventions.

In this episode, Meg Bomley shares her T1D journey from being diagnosed at 18 years old and spending eight years on MDI without a CGM, to becoming someone who feels deeply empowered in her body and her diabetes.Meg first came on the podcast in 2022 after graduating from Risely coaching. At the time, she had just come out of a season of constant lows, burnout, and feeling completely overwhelmed after switching to a pump without the support she needed.Today, she's back as a nationally board certified health coach, and 35 weeks pregnant with type 1 diabetes, one of Risely's top coaches.The majority of this conversation is the reality of navigating pregnancy with T1D: the nausea, insulin resistance, fear of highs, changing carb ratios, and learning to trust yourself in this season.WHAT WE COVER:Why Meg resisted pumps and CGMs for nearly 8 years after diagnosisThe “biggest disaster ever” that happened when she first switched to a pumpWhat finally helped her stop feeling resistant, overwhelmed, and burnt out with diabetesHow coaching helped her uncover mindset blocks that had nothing to do with insulin or carb countingThe first sign Meg noticed that told her her insulin resistance was changing after getting pregnantHow she managed nausea, vomiting, insulin on board, and eating mostly carbs during pregnancyThe difference between taking 5 units for oatmeal pre-pregnancy vs. 16 units during pregnancyWhat it's actually like mentally to watch yourself take “large amounts of insulin” every dayWHAT'S NEXT:

In this episode of the Your Diabetes Insider Podcast, I'm breaking down how I personally handle Memorial Day BBQs and cookouts without my blood sugars going completely off the rails. From grazing on appetizers, hidden carbs in "simple" foods, and delayed fat spikes, to figuring out insulin timing, pre-bolusing, and using activity to boost insulin sensitivity before you even show up - this is everything I wish I knew earlier. If BBQs usually turn into a CGM stress-fest for you, this will help you feel more prepared so you can actually enjoy the food, the people, and the day without constantly worrying about your blood sugar! Want the best blood sugars you've ever had while enjoying great food? Peep this: https://www.yourdiabetesinsider.com/coaching   RESOURCES: Download these FREE guides that will help you on your diabetes, nutrition, and exercise journey! https://www.yourdiabetesinsider.com/free-stuff LET'S TALK! Instagram: @yourdiabetesinsider Tiktok: @yourdiabetesinsider

Send us Fan MailHello and welcome to CGM Presents: In the Word. My name is Dr. Stephanie Wright. On behalf of Charles George Missions, welcome to Season 14, “Spiritual Warfare.” This is episode 8, and we are starting a new series, “Spiritual Warfare Scriptures.” The resource for this series is the book “Spiritual Warfare Manual: ABC to PhD,” written by yours truly.We will focus on one scripture each time we meet, and these will be vignettes or very short presentations. Use these scriptures to build up your arsenal for spiritual warfare by memorizing, meditating and implementing them into your daily walk with the Lord.Today's scripture is from Isaiah 54:17, No weapon that is formed against YOU shall prosper; and every tongue that shall rise against YOU in judgment YOU shall condemn. This is the heritage of the servants of the Lord, and their righteousness is of me, saith the Lord.Why is this such a popular scripture? I believe it's popular because it represents victory in whatever turmoil, task, or terror that the enemy tries to attack you with. No weapon means “no weapon,” but it does not mean a weapon won't be formed; it means the weapon will not prevail against you.No weapon formed against you will meet its intended end. So, if someone is trying to destroy you, physically, mentally, financially—they are not going to succeed because God will step aside and let the enemy turn on them, and they in turn will start fighting against each other. I have experienced this firsthand. God stepped aside and allowed the enemy to attack my enemies, and then those same enemies started turning on each other.Let's look at the second half of Isaiah 54:17. People often overlook the second half of this verse, and every tongue that shall rise against YOU in judgment YOU shall condemn. This is the heritage of the servants of the Lord and their righteousness is of me, saith the Lord.This tells us that the words people speak are weapons but again, their word weapons will not prevail against you. But what does this scripture tell us to do when words are spoken against us in judgment? It is our right—our heritage because Jesus gave us that right through His victory on the Cross—our responsibility to speak against those things and speak good things into our lives. This is why we need to know the Word of God. This is why we need scriptures in our arsenal so we can wage spiritual warfare against Satan and his demonic forces. This is why in this series, we are studying scriptures on spiritual warfare to prepare you   formed against you shall prosper.”Thank you for joining us today. We look forward to sharing another scripture on spiritual warfare next time.Now, let's turn to Dr. Charles, who will tell you how you may reach us and comment on this podcast. If you want to contact us or comment on this podcast, please visit our website and select www.cgmissions.com/podcasts, where all episodes are available by category in series format. You can see some video and audio podcasts at: www.youtube.com/@cgmissionsinc then select from the video or podcast"Playlist."   CGM is a 501(c)(3) nonprofit. Donations may be made on our website:https://www.cgmissions.com/donate-here-general-and-wecare/

It's In The News, where we bring you the top diabetes stories and headlines happening now. Top stories this week: Dexcom shares details of its next generation CGM, T1D and GLP-1 studies, weight loss management on GLP-1 medications updates, all-in-one CGM and pump, and more! Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcript: XX Dexcom announces some features of it's next generation CGM – the G8. We've been talking about this with CEO Jake Leach for a while now – it will be a 50% smaller with what they're calling advanced sensing capabilities. According to Leach, G8 will adapt to the physiologic variability of each user. It has additional technology built in, based on a new silicon chip design and algorithm. 15 day wear is now the baseline for all Dexcom sensors moving forward. At launch the G8 will only measure glucose but the plan is for a multi-analyte version to follow. That would measure ketones and potassium. Ketones we know – but potassium is very important for people with kidney and possible for people taking some diabetes meds. It's an interesting space to watch.. btw, analyte is just a medical word for the specific thing you're measuring – the target of the test you're running. we're going to hear that word a lot I think..   Looks like an FDA submission for the G8 next year.. with an outside the US launch the following year. https://www.drugdeliverybusiness.com/dexcom-unveils-next-gen-g8-cgm/ XX Glucotrack has submitted its implantable continuous blood glucose monitor (CBGM) for FDA IDE, that's investigational device exemption and would enable the company to initiate a U.S. clinical study for the fully implantable technology. Rutherford, New Jersey-based Glucotrack's device features no on-body external component. The company aims to offer it for three years of continuous, accurate blood glucose monitoring for a more convenient, less intrusive solution. Unlike traditional CGMs that measure glucose in interstitial fluid, the CBGM measures glucose levels directly from the blood. The implant goes five centimeters within the subclavian vein. Glucotrack's active implantable device has a small battery and some electronics that go just under the skin in the pectoral region. The location of the implant is not in a major vessel, but the implant can measure real-time glucose levels as pulsatile blood flows over the tip of the sensor. https://www.drugdeliverybusiness.com/glucotrack-submits-long-term-implantable-cbgm-fda-ide/ XX PharmaSens today announced the publication of data from the first clinical study evaluating its all-in-one insulin patch pump offering. The all-in-one pump pairs the Niaa Essential insulin patch pump with the SynerG continuous glucose monitor (CGM) sensor developed by Pacific Diabetes Technologies. However, this system would be one device that features both the pump and CGM technology.   PharmaSens and SiBionics also have a collaboration aimed at developing the all-in-one solution. They are jointly developing the next-generation Niia insulin patch pump with a SiBionics CGM. PharmaSens expects a second feasibility study in the second quarter to evaluate the next-generation pump with SiBionics' CGM.   PharmaSens says the clinical feasibility study of Niia demonstrated for the first time ever that the combined offering is, in fact, feasible. It believes its device addresses the need for alternatives to multi-device diabetes management. systems.   Aggregated MARD for the investigational device came in at 11.6%. A MARD target of less than 10% is considered ideal for CGM devices, but PharmaSens said that, in the context of the early feasibility study, the results were encouraging and provide evidence supporting the development of an all-in-one system. https://www.drugdeliverybusiness.com/pharmasens-efs-insulin-patch-pump-cgm/ XX   XX ViCentra launches the newest version of the Kaleido pump system in Europe. This is that small colorful pump, with Diabeloops algorithm and the Dexcom G7. It'll be in Germany and the Netherlands later this summer. https://hellokaleido.com/vicentra-announces-commercial-launch-of-new-smartphone-controlled-kaleido-automated-insulin-delivery-patch-pump-system/--   XX Diabeloop just got CE Mark approval for DBLG2 integrations – it's latest AID platform the company has kicked off the gradual European launch of the technology. It currently offers DBLG2 as a smartphone application on Android, with iOS integration coming soon. As you just heard, it's integrated with kaleido and the company says it plans to make additional configuration for DBLG2 with alternative pumps "available soon." Running on a user's smartphone, DBLG2 works as a self-learning algorithm. It continuously analyzes glucose data, calculates insulin needs in real time and automatically adjusts delivery. https://www.drugdeliverybusiness.com/diabeloop-fda-next-gen-algorithm-g7/   XX Among adults with type 1 diabetes (T1D), the initiation of GLP-1-based therapy was associated with a lower risk for all-cause death, several cardiovascular outcomes, all-cause hospitalisations, and hypoglycaemia, without a higher risk for diabetic ketoacidosis.   METHODOLOGY: Researchers in Greece conducted a retrospective cohort study utilising real-world data from a global health research network to evaluate the association between GLP-1-based therapy and cardiovascular and renal outcomes in adults with T1D. A total of 4088 patients receiving GLP-1-based therapies (median age, 43 years; 34.3% men) were propensity score matched with an equal number of patients not receiving the treatment. The risk for hypoglycaemia was lower with GLP-1-based therapy (hazard ratio, 0.72; P = .021); however, the risk for diabetic ketoacidosis did not differ significantly between the two groups. https://www.medscape.com/viewarticle/glp-1-drugs-tied-cardiovascular-benefits-t1d-2026a1000fbx   XX Eli Lilly and Company (NYSE: LLY) today announced detailed results from two late-phase trials showing that people with obesity maintained their weight loss long term with either Foundayo or lower-dose Zepbound after switching from higher doses of injectable incretin therapy. The findings from SURMOUNT-MAINTAIN and ATTAIN-MAINTAIN, were presented at the 33rd European Congress on Obesity (ECO) and published in The Lancet and Nature Medicine, respectively.   "Weight regain remains one of the biggest challenges in obesity care, and is often the result of treatment interruptions that cause biology to work against patients, undoing the progress they've made," said Louis J. Aronne, M.D., FACP, DABOM, founder and Chair Emeritus of the American Board of Obesity Medicine, former president of The Obesity Society, Fellow of the American College of Physicians, world-renowned obesity specialist and Lilly consultant. "These medicines can be used for long-term maintenance today, and results from SURMOUNT-MAINTAIN and ATTAIN-MAINTAIN provide additional evidence of their potential when switching from higher doses of injectable incretin therapy." https://investor.lilly.com/news-releases/news-release-details/lillys-foundayo-and-lower-dose-zepbound-helped-people-maintain XX Scientists in Sweden have developed a more reliable way to create insulin-producing cells from human stem cells. These lab-grown cells not only respond strongly to glucose but were also able to restore blood sugar control when transplanted into diabetic mice. When transplanted into diabetic mice, the cells gradually restored the animals' ability to regulate blood sugar. Long way to go, as we say with most of these mice studies. https://www.sciencedaily.com/releases/2026/05/260505234620.htm XX Interesting look at how the body controls sugar storage – apparently this finding challenges long-standing biology concepts and could open new directions for disease treatment. Published in Nature, the study describes a potential method for directly reducing glycogen, the stored form of sugar in the body. These scientists discovered that glycogen can be directly regulated by ubiquitin, a protein best known for marking damaged proteins for recycling or removal. The study is the first to show that ubiquitin can regulate glycogen in humans, overturning more than 50 years of scientific understanding. Excess glycogen is also associated with more common health problems, including diabetes, obesity, liver disease, and heart disease.       https://scitechdaily.com/scientists-just-rewrote-biology-hidden-mechanism-could-transform-diabetes-treatment/ XX A new Oklahoma law will give parents the option to have their children screened for Type 1 Diabetes.   The measure passed with overwhelming bipartisan support in the Legislature and takes effect Nov 1. Oklahoma consistently ranks among the states with the highest rates of diabetes and diabetes-related deaths. The law gives parents access to antibody testing that can detect risk years before symptoms develop, helping families take preventive action and avoid emergency room visits. https://journalrecord.com/2026/05/11/oklahoma-law-expands-access-type-1-diabetes-screening/ XX More to come including a new study trying to figure out why some people are more likely to develop diabetes, a look at cannabis and preventing metabolic disorders, and XX   A National Institutes of Health (NIH)-funded study has identified key differences in human pancreatic islet cells that may help explain why some people are more likely to develop diabetes. Researchers found that the mix of hormone-producing cells in the pancreas varies widely from person to person, and that variation plays a central role in how the body regulates blood sugar. The study involved a deep dive into islet cell function that is linked to donor traits associated with observable characteristics, or phenotype, such as sex, race and ethnicity, as well as genetic information, or genotype, including predicted ancestry and genetic risk for both type 1 and type 2 diabetes. The findings highlight that islet cell composition, rather than the physical size and shape of islets, is a key factor in regulating hormone release. The team found that the makeup of pancreatic islets plays a major role in how effectively they release insulin and glucagon — key hormones that regulate blood glucose. Islets with a higher proportion of insulin-producing beta cells showed stronger insulin secretion in response to various stimuli, while higher levels of alpha and delta cells were generally linked to reduced insulin output. In addition, the researchers found that islet hormone secretion is affected by donor traits, such as sex, race and ethnicity and their genetic makeup, including ancestry predicted from genetic testing and genetic risk for type 2 diabetes. Combined, the findings of the study have significant implications for understanding the factors that may predispose people to diabetes. "This study is the tip of the iceberg," said Dr. Evans-Molina. "We hope this dataset becomes useful to the entire diabetes research community and that researchers use it to answer questions about the genotype-phenotype correlation within these data."   https://www.nih.gov/news-events/news-releases/nih-funded-study-maps-human-pancreatic-islet-cells-offering-new-clues-diabetes-risk XX XX XX Research published recently in JAMA Network Open offers illuminating evidence suggesting there is a positive association between GLP-1 agonists—drugs commonly used to treat obesity and diabetes—and better outcomes among breast cancer patients.   "This study suggests that GLP-1 drugs may offer protective benefits potentially improving survival and recurrence risk in some female patients with breast cancer – whether this is related to weight control, improve cardiovascular health or other mechanisms remains to be studied," said study senior author Bernard F. Fuemmeler, Ph.D., MPH, associate director for population sciences and the Gordon D. Ginder, M.D., Chair in Cancer Research at VCU Massey Comprehensive Cancer Center.   Breast cancer patients who are also obese or have type 2 diabetes experience more aggressive cancer growth and worse outcomes. Prior studies have shown that weight loss treatment and surgery following a breast cancer diagnosis are associated with improved heart health and increased survival.   What are GLP-1 drugs? Glucagon-like peptide-1 receptor agonists (GLP-1 RAs). Approved to treat type 2 diabetes in 2005 and weight management in 2021. Impacts on breast cancer survival and recurrence are still unclear. Since 2020, the use of these drugs has increased dramatically, where approximately 12% of Americans have used GLP-1s for weight loss, according to a RAND report.   The research findings Through a retrospective cohort study examining the electronic health records of more than 840,000 breast cancer patients who were diagnosed between 2006 and 2023, the results suggest there is a potential link between GLP-1 RAs and improved outcomes among breast cancer patients who are also obese or have type 2 diabetes.   GLP-1 RA use was associated with an overall lower risk of death from any cause over a 10-year follow-up period among breast cancer patients. Additionally, breast cancer survivors who used GLP1-RAs for diabetes or obesity had a significantly lower risk of their cancer returning over 10 years following their initial treatment.   "Our findings align with emerging preclinical research and contribute to a growing body of literature related to GLP-1 RA use in oncology settings," said study lead author Kristina L. Tatum, PsyD, MS, of the VCU School of Public Health.   What's next? Further studies are needed to understand the biological mechanisms, if any, between GLP-1 RAs and breast cancer outcomes. The research team intends to further evaluate these correlations through randomized clinical trials.   "Our study underscores the potential of GLP-1 RAs as an adjunct strategy for improving cancer-related outcomes among patients with breast cancer, although clinical trials are needed to inform effective therapeutic approaches and clinical decision making," Fuemmeler said. https://www.oncology-central.com/could-glp-1-receptor-agonists-improve-outcomes-for-breast-cancer-patients-with-obesity-or-with-type-2-diabetes/ XX Researchers at UC Riverside gave cannabis to obese mice and found that not only did the rodents lose weight, but when given a concentrated cannabis oil, the mice also saw striking benefits in their metabolic function. DiPatrizio said his team studied the issue to better understand why cannabis users show significant reductions in weight and risk for diabetes compared with nonusers. "We would think that chronic cannabis users would be eating more and weigh more, but it's just the opposite," DiPatrizio said. Scientists are increasingly examining the possibility that cannabis compounds could fight obesity or metabolic disorders like diabetes. Cannabinoids interact with the body's endocannabinoid system, which partially controls nearly every aspect of our physiology, including metabolism and appetite. That creates the possibility that targeting this widespread system could unlock new therapies for these conditions. https://www.sfgate.com/cannabis/article/cannabis-weight-loss-california-study-22255328.php XX A new campaign launched by diaTribe and Genentech aims to empower and educate people about diabetes-related eye disease. Here's what you can do today to protect your eye health. To help address these barriers, diaTribe and Genentech partnered to launch All Eyes on DME, a new campaign that aims to spread awareness and educate people at-risk for or living with diabetes-related eye conditions like DME. Also partnering in the campaign is actor and comedian Damon Wayans, who wanted to share his journey (and, of course, a joke or two) with type 2 diabetes to open up the conversation about what is often a stigmatized or less talked about topic: eye health and diabetes.   One of these important conversations happened recently at the All Eyes on DME launch in New York City, where Wayans joined a panel of experts, advocates, and people living with DME to talk about diabetes-related eye disease and how to help prevent it. https://www.alleyesondme.com/dme-in-the-spotlight.html https://diatribe.org/diabetes-complications/all-eyes-dme-new-campaign-spotlights-eye-health-and-diabetes

Rafael Pepen was diagnosed with Type 1 diabetes at 17, right in the middle of rehearsing for his very first musical in the Dominican Republic. Without access to a CGM or carb counting education, he learned to manage largely on instinct. Years later, he moved to the US, pursued his dream of performing professionally, and eventually landed at Disney, where he now performs five high cardio shows a day.In this episode, Rafael sits down with Lauren to talk about what it actually looks like to manage T1D in a life that never slows down. He shares the months of burnout, panic attacks around lows, and constant roller coaster blood sugars that led him to seek coaching, and what shifted on the other side of that.WHAT WE COVER:What it was like to be diagnosed at 17 in the Dominican Republic with limited access to education, CGMs, or carb counting guidanceThe unique challenge of managing T1D across five high cardio shows a day and why it is a completely different beast from a traditional performance scheduleThe moment things started to unravel at Disney and what five months of daily lows, panic attacks, and burnout actually felt like from the insideWhat shifted when Rafael started working with a Risely coach and the tools that made the biggest difference for his day to day managementThe emotional side of T1D that most people never talk about, including what it felt like to cry during a low and the moment that started to changeWhat Rafael is still working toward and the one thing he wants most from his relationship with diabetes going forwardWHAT'S NEXT:

Click to Send us a text!We challenge the idea that constant snacking boosts metabolism and explain how all-day grazing can keep insulin elevated and slowly erode energy, focus, and recovery in motorsports. We translate insulin resistance into real race-day consequences and lay out a clearer plan for meal rhythm, testing, and metabolic flexibility. • why “always fed” habits can create subtle crashes and brain fog • what insulin does and how chronic elevation leads to insulin resistance • common race weekend fueling patterns that keep glucose spiking • why context matters for athletes and why fasting is not for everyone • performance costs in motorsports like slower decisions and slower recovery • early detection with hemoglobin A1C and advanced at-home testing • using a CGM to see food, stress, sleep, and travel effects in real time • practical anchors like the 30/ 10/ 3 rule, strength training, sleep, and stress reduction • post-meal movement to rebalance blood sugar fast be sure to click that subscribe button so you never miss an episode. If you're serious about optimizing performance at the root level, you can apply to work with Victory Lane Wellness at victorylanewellness.com Support the showAs a token of gratitude, of course you're interested in these FREE and powerful resources, and because you enjoy the show, first be sure to leave your 5-STAR Review HERE!

In this Q&A episode of Your Diabetes Insider Podcast, I'm Ben Tzeel and I'm answering real questions you've sent in about living with Type 1 Diabetes - including CGM placement, insulin dosing, insulin pumps, food choices like "healthier" cereals (Magic Spoon, Catalina Crunch), walking for blood sugars, and what to do when things don't go perfectly. I also cover gestational diabetes, exercise, and how to actually make day-to-day diabetes decisions feel simpler and more doable without overthinking everything! Want the best blood sugars you've ever had while enjoying great food? Peep this: https://www.yourdiabetesinsider.com/coaching   RESOURCES: Download these FREE guides that will help you on your diabetes, nutrition, and exercise journey! https://www.yourdiabetesinsider.com/free-stuff   LET'S TALK! Instagram: @yourdiabetesinsider Tiktok: @yourdiabetesinsider

GET HEIRLOOM SEEDS & NON GMO SURVIVAL FOOD HERE: https://heavensharvest.com/wam USE Code WAM to save 25% plus free shipping! Pledge here! Just a dollar a month can help us alive! https://www.patreon.com/user?u=2652072&ty=h&u=2652072 EXCLUSIVE replays of hour plus long live shows are available here at $5 a month or more! BUY GOLD HERE: https://firstnationalbullion.com/schedule-consult/ Avoid CBDCs! GET 10% OFF ON SHILAJIT FROM DR. KAUFMAN WHEN YOU USE CODE WAM10 HERE: https://medauthentica.com/discount/WAM10?redirect=/products/authentica-shilajit%3Fsca_ref=10867124.wrNV3jkYSaMg9 HELP SUPPORT US AS WE DOCUMENT HISTORY HERE: https://gogetfunding.com/help-keep-wam-alive/# Josh Sigurdson reports on the massive supply chain crisis effecting essentially the entire world as shipping giants Maersk, Hapag-Lloyd, MSC, CMA and CGM create a new shipping route by-passing the Strait of Hormuz by dropping off boat loads, driving across the country and then loading everything back on to other boats. Costs are about to skyrocket but it's far worse than just costs. The ability to obtain food, fertilizer and oil are about to collapse in a way never before seen in modern history. They are manufacturing a famine to force people into a ration-based digital ID system complete with social credit. Costs of potatoes alone went from 2.5 Euros to 18.5 Euros per 100kgs in a single month due to fertilizer shortages which farmers have been warning about for quite some time. Sulfuric acid is at a major deficit currently which leads to shortages of fertilizer as well as tools needed for mining and manufacturing across the board. This alone can cause a famine. On top of this however, we were already seeing an attack internationally on farmland as well as 73 year shortages of cattle head. Farm bankruptcies are up 46%. 70% of farmers cannot afford fertilizers. Diesel prices are up 60% in a year. President Trump recently said in an interview with Sean Hannity that high gas prices are the price we pay for Iran not having nuclear weapons. This is insanity. Meanwhile, engine oil is scarce and data centers are being built everywhere to complicate matters more. Water shortages will be a major problem in cities near data centers as people like Mike Adams has warned about on Natural News. This will hurt farms and industry while the data centers collect everyone's information in a massive surveillance database. They're creating a Hive Mind to help "solve" the very shortages they created in the first place. It just so happens that back in July of 2025, the DOE (Department of Energy) warned that we will see a 100x increase in blackout risks by 2030. That year isn't a coincidence. The United Nations planned for this years ago. It also just so happens that government run grocery stores are being established in New York and proposed in California and cities like Chicago. In the UK where they are pushing forward a digital ID mandate, they are attempting to police what foods you buy. This is one of the many steps towards the digital gulag system to come. From banks to energy and food, this system which the WEF has pushed for years is being adopted, quickly. It's up to you to actually take the warning and do something about it or sit there on your hands awaiting you dark fate. Stay tuned for more from WAM! GET YOUR WAV WATCH HERE: https://buy.wavwatch.com/WAM Use Code WAM to save $100 and purchase amazing healing frequency technology! Get Your SUPER-SUPPLIMENTS HERE: https://vni.life/wam Use Code WAM15 & Save 15%! Life changing formulas you can't find anywhere else! Get local, healthy, pasture raised meat delivered to your door here: https://wildpastures.com/promos/save-20-for-life/bonus15?oid=6&affid=321 USE THE LINK & get 20% off for life and $15 off your first box! DITCH YOUR DOCTOR! https://www.livelongerformula.com/wam Get a natural health practitioner and work with Christian Yordanov! Mention WAM and get a FREE masterclass! You will ALSO get a FREE metabolic function assessment! GET YOUR APRICOT SEEDS at the life-saving Richardson Nutritional Center HERE: https://rncstore.com/r?id=bg8qc1 Use code JOSH to save money! PayPal: ancientwonderstelevision@gmail.com FIND OUR CoinTree page here: https://cointr.ee/joshsigurdson PURCHASE MERECHANDISE HERE: https://world-alternative-media.creator-spring.com/ JOIN US on SubscribeStar here: https://www.subscribestar.com/world-alternative-media For subscriber only content! BITCOIN ADDRESS: 18d1WEnYYhBRgZVbeyLr6UfiJhrQygcgNU World Alternative Media 2026

Send us Fan MailThe Blood Sugar Rhythm Webinar is coming May 21st, 2026, at 8:00 PM CSTWaking up at 2:47 or 3:00 a.m. with a racing heart, sweaty heat, and a loud “I need to eat” signal can make you feel like your sleep is broken. We take a different angle: What if that hunger is actually a blood sugar crash, and the real culprit is a stress-hormone surge that yanks you out of deep sleep?We walk through the crash-rescue cycle step by step, from dinner-time insulin to overnight glucose drops, and why your adrenal glands respond with cortisol and adrenaline to protect your brain. That protective response can leave you wide awake with anxious energy, restless legs, and racing thoughts that don't even make sense at the time. We also explain why common tests like fasting glucose and hemoglobin A1C can look perfectly normal while nocturnal hypoglycemia and blood sugar swings keep happening in the middle of the night.We connect the dots for women's health as well, including why symptoms can worsen in the luteal phase when progesterone rises and increases insulin resistance, why estrogen changes can shift insulin sensitivity, and why perimenopause can be the first time you notice this pattern. Finally, we talk about practical next steps, including using a continuous glucose monitor (CGM) to capture real-time overnight data and get answers you can actually use.If you're tired of guessing, listen now, share this with a friend who wakes up at 3 a.m., and subscribe so you don't miss what's next. After you listen, will you leave a quick review and tell us what your wake-up time tends to be?Welcome to the Art of Healing Podcast community. This podcast is devoted to helping you find what works on your journey to health and wellness. This podcast is devoted to providing information on many healing modalities. Learn more about:ReikiFunctional MedicineMeditationEnergy Healingand more!Learn more about Dr. Charlyce here. Never miss an episode of Art of Healing Podcast...the podcast devoted to helping you heal your mind, body and spirit.Sign up for my weekly newsletter, and never miss an episode along with other great content:Art of Healing PodcastStay in touch socially here:Healing Arts LinksLearn more about me and my offerings here:Healing Arts Health and Wellness

Rob sits down with Dr. Gregory Dodell, an endocrinologist from New York City and one of the more honest voices in the diabetes space online. What starts as a conversation about why a doctor would bother making Instagram videos turns into something a lot more real, a candid look at what actually happens between patients and their providers, why those relationships succeed or fall apart, and what it takes to feel like a full person inside a system that was mostly built around numbers. Dr. Dodell talks about the thing he keeps learning from patients that wasn't in any textbook: stress. How it silently drives blood sugars up, how burnout and over-fixation on every CGM reading can quietly hollow out your quality of life, and why a slightly elevated number is sometimes worth it if it means you actually got to live your day.  It's not a permission slip to ignore your management. It's a reminder that the goal was never the A1C itself. The goal was always life on the other side of it. They also dig into the infrastructure problems that make good diabetes care so hard to deliver, the prior authorization nightmare, the endocrinologist shortage, and the 20-patient days that leave almost no room to actually sit with someone.  Dr. Dodell shares, for the first time publicly, that he's moving toward concierge primary care, not out of ambition, but out of frustration with a system that makes it structurally almost impossible to do the job he trained for. If you've ever left an endo appointment feeling like you only got halfway through what you needed to say, or worse, left feeling judged, this one's for you. Chapters: 00:00   Who is Dr. Gregory Dodell? 01:41   Why HCPs Are Becoming Content Creators 04:06   Reaching Patients Beyond the Office 05:16   Preparing for Short, High-Stakes Endo Visits 06:29   Fitting Everyone Into One Box Doesn't Work 07:18   Listening First — How to Read the Room 08:26   The Surprising Role of Stress on Blood Sugar 09:59   Diabetes Distress and Over-Fixation on Numbers 10:35   Quality of Life vs. Perfect Blood Sugar Control 11:37   There's More to Life Than an In-Range Number 13:33   Complications — Compassion Over Judgment 14:59   Stigma, A1Cs, and the Morality Trap 16:03   How Patients Have Been Traumatized by Healthcare 17:37   The Endocrinologist Shortage Crisis 20:04   Prior Authorizations — A System-Wide Failure 24:38   Dream Scenario: What Ideal Diabetes Care Looks Like 26:10   Concierge Medicine and the Future of the Endo Practice (First Announcement) 28:44   Exciting Research — T-ZELD, GLP-1s, Autoimmune Breakthroughs 32:47   How to Find and Advocate for Yourself with Your Endo Resources: * Dr. Gregory Dodell on Instagram (@EverythingEndocrine) * Central Park Endocrinology

Get Dr. Vonda's insights Want to understand what's happening in your body — and what to do next? Each week, Dr. Vonda shares science-backed guidance on strength, bone health, muscle, and longevity — the same way she speaks to her patients. Clear. Practical. No noise. Join the newsletter: https://manage.kmail-lists.com/subscriptions/subscribe?a=YqJKtR&g=Ww3gx3& Your blood sugar is telling you everything. You just haven't been listening. In this episode, I sit down with registered dietitian and certified personal trainer Kayla Girgen, one of the first clinicians to bring continuous glucose monitoring to everyday women who do not have diabetes. If you have ever eaten well, exercised hard, and still felt like your body was working against you, this conversation will change the way you see your metabolism forever. What We Explore: - How a CGM reveals what food, stress, sleep, and exercise are doing to your blood sugar in real time. - Why pre-diabetes is one of the most under-treated diagnoses in women's health. - Why fasting insulin is the number you actually need. - What your blood sugar crashing at 3am has to do with why you cannot get back to sleep. - How to eat enough protein without overhauling your entire routine overnight. - Why rucking is one of the most practical tools for building strength, improving body composition, and boosting bone density. About Kayla Girgen KAYLA GIRGEN, RD, LD, CPT, is a registered dietitian, certified personal trainer, and founder of Sugar + Strength Academy—an online wellness community helping women balance blood sugar and build strength, one step at a time. She blends real-life tools, such as continuous glucose monitoring (CGM), with accessible movement, like rucking, to help clients break free from diet extremes and feel strong—both physically and mentally. Kayla's approach centers on progress over perfection and creating results that work in real life. Her upcoming book Ruck Fit shares how rucking became a catalyst for reclaiming her physical and mental health, proving that fitness doesn't have to be complicated to be life-changing. Connect with Kayla Girgen: Website: https://kaylagirgenrd.com/ Instagram: https://www.instagram.com/kaylagirgenrd/  LinkedIn: https://www.linkedin.com/in/kaylagirgen/ YouTube: https://www.youtube.com/@kaylagirgenrd Facebook: https://www.facebook.com/kaylagirgenrdld TikTok: https://www.tiktok.com/@kaylagirgenrd Book - RUCK FIT: Build Strength and Endurance by Walking with Weight Available here: https://a.co/d/06vLg5nR Timestamps 00:00 Intro 03:30 How Stress Shows Up on Your Blood Sugar 09:30 Why Pre-Diabetes Is a Five-Alarm Fire 13:00 Glucose Typing: Are You a Compensator or a Spiker 16:25 What to Do If Your Blood Sugar Spikes and Crashes 20:40 How Long Should You Actually Wear a CGM 24:00 How to Calculate Your Daily Protein Goal 29:10 GLP-1s and the Changing Weight Loss Landscape 34:50 Why Eating Too Little Is the Biggest Mistake Midlife Women Make 37:00 Rucking: What It Is and Why It Works for Women 40:00 How Adding Weight Increases Your Training Load by 10 Percent 45:00 The Top Three Priorities for High-Achieving Women Feeling Stuck 51:20 Rapid Fire: CGM, Carnivore, and Habits Start your Unbreakable journey Most women are never given a clear plan for how to stay strong as they age. The Unbreakable Lifestyle is where that changes. This is the home of Dr. Vonda's method — built from 20+ years of clinical work and designed for real life. Inside: - Unbreakable Assessment — know exactly where you stand - Training plans — build muscle, protect bone, improve performance - AI Dr. Vonda — get answers and guidance anytime - Community — women committed to staying strong and engaged - Exclusive education — what actually works, all in one place This is not another program. This is how you build strength — with direction. Join the Unbreakable Lifestyle: https://www.theunbreakablelifestyle.com/ Build stronger bones Bone loss starts earlier than you think — and speeds up in midlife. Dr. Vonda's Unbreakable Bone Health formula supports bone density, strength, and long-term skeletal health with clinically researched ingredients. Foundational. Not optional. Shop now: https://shop.drvondawright.com/?utm_s   Read the book Unbreakable: A Woman's Guide to Aging with Power A clear, science-backed roadmap to building strength, supporting your body, and taking control of how you age. Get your copy: https://theunbreakablebook.com?utm_so    About Dr. Vonda Wright Dr. Vonda Wright is an orthopedic sports surgeon and leading expert in women's health and longevity. For over 20 years, she has helped women build muscle, strengthen bone, and extend their health span — with science, not guesswork. Her mission is simple: help women age with power.   Connect with Dr. Vonda Instagram: https://www.instagram.com/drvondawright Substack: https://drvondawright.substack.com/ TikTok: https://www.tiktok.com/@drvondawright LinkedIn: https://www.linkedin.com/in/vonda-wright-md-ms-2803374 Website: http://www.drvondawright.com

Three women who've spent years inside the PCOS conversation — one as a clinician, one as a hormone tracking specialist, one as a board-certified OBGYN and culinary medicine physician — and they still said, out loud, that nobody has all the answers. That alone makes this episode worth your time.Today Dr. Susan Fox is joined by Rose McKenzie, clinical manager at Mira, and Dr. Basma Faris, founder of her namesake practice and creator of the Adopt a Mediterranean Diet for PCOS course, for a conversation about what it actually looks like to track, understand, and act on your own hormonal and metabolic data — especially when you have PCOS.Mira is a medical-grade at-home hormone monitor tracking four hormones using fluorescent technology. A CGM — continuous glucose monitor — shows you in real time how your blood sugar responds to food, stress, sleep, and where you are in your cycle. Together, these tools are changing what it means for a woman with PCOS to know her own body.You'll learn why PCOS is a metabolic disorder on a spectrum — and why where you are on that spectrum is not where you have to staywhat a 2023 University of Toronto study revealed about how glucose levels shift between the follicular and luteal phases — and what that means if you have insulin resistancewhy 70% of people with PCOS have insulin resistance — and why the other 30% matters just as muchhow high insulin drives testosterone production, how testosterone impairs insulin sensitivity, and why breaking that cycle requires interrupting it at multiple points simultaneouslywhat Mira hormone data actually looks like in a postpartum breastfeeding woman with PCOS — and why this population is almost always missedwhy elevated fasting glucose and elevated post-meal glucose are two different problems pointing to two different root causeshow long to use a CGM before you've learned what you need to know, and what "glucorexia" is — and why more data isn't always better.This episode is for you if you have PCOS and feel like every protocol you've tried was designed for someone else;, you're postpartum and nobody has looked closely at your hormones; you're tired of being told what to eat without being monitored when you follow the rules; you want to understand the insulin-testosterone feedback loop in plain language; you're a provider curious about integrating hormone and metabolic

What if your body could warn you before a relapse happens? In this fascinating episode, Dr. Vera Tarman sits down with Bob Messerschmidt — biomedical engineer, inventor, and one of the architects behind the original Apple Watch's health-sensing technology — to explore a surprisingly simple but powerful biomarker: the erythrocyte sedimentation rate (ESR). Bob is the founder of Core Health and has developed an FDA-registered at-home device that tracks chronic low-grade inflammation over time. For those of us in the food addiction and recovery world, this conversation opens a compelling new door: could inflammation tracking be the missing feedback loop for people working to stay abstinent from ultra-processed foods?

It's In The News - where we bring you the top diabetes stories and headlines happening now. This week, Tzield approved down to age one and over, Omnipod trials for fully closed loop, Tandem approved for pregnancy, Eversense 365 launches in Europe, generic Ozempic in Canada, an award for the T1D Barbie and more.  Announcing Community Commericals! Learn how to get your message on the show here. Don't miss our in-person events: www.diabetes-connections.com/events  Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Okay.. our top story this week: XX The U.S. Food and Drug Administration (FDA) approved Tzield (teplizumab-mzwv) for use in children in stage 2 type 1 diabetes (T1D) ages one and older. The approval expands the previous indication from those aged eight and above and was granted under a priority review process. This decision is supported by one-year data from the PETITE-T1D Phase IV study, which evaluated the safety and pharmacokinetics of Tzield in children under eight years old. Tzield was approved for use in individuals 8+ in stage 2 T1D in 2022. Since then, we have been working to expand the eligible population. This expansion effort includes individuals in stage 3 T1D, who can preserve endogenous insulin production for longer when they take Tzield and, most notably today, children in stage 2. https://www.breakthrought1d.org/news-and-updates/tzield-approved-for-children-ages-one-and-older-in-stage-2-t1d/   XX Big write up in the journal Pediatrics about screening for type 1. Citing the 2025 ADA Standards of Care in Diabetes, the opinion piece talks about how to engage the greater healthcare community.  It says: We aim to encourage the development of strategies to emphasize the importance of T1D early detection, integrate screening into routine health care encounters, and support implementation of T1D screening. Pediatricians and other primary care clinicians are well positioned for greater collaboration with the multidisciplinary team, ensuring early detection, timely intervention, and improved outcomes. https://publications.aap.org/pediatricsopenscience/article/2/2/1/207272/Type-1-Diabetes-Screening-in-Pediatrics-Putting?autologincheck=redirected   XX More info about GLP-1 drugs and people with type 1. New study shows off label use did not lead to DKA or pancreatitis in a large 1-year single-center study. Moreover, GLP-1 agonist use in people with T1D was associated with lower overall rates of hospitalization, as has occurred in type 2 diabetes Although GLP-1 agonists are not approved by the FDA for T1D management, off-label adjunctive use has risen for those with obesity. Semaglutide was the most commonly-used GLP-1 (65.5% of GLP-1 users) followed by tirzepatide (23.5%). The rest were using the older-generation drugs: liraglutide or dulaglutide. Lots more information to come on type 1 and glp 1-s in upcoming studies. https://www.medscape.com/viewarticle/use-glp-1s-type-1-diabetes-not-linked-increased-dka-2026a1000d56 XX Health Canada ‌​has approved the first generic ​version of ​Danish ⁠drugmaker ⁠Novo ‌Nordisk's Ozempic drug. In January 2026, the Canadian patent for Ozempic will expire, paving the way for cheap generic versions of the semaglutide injections that help regulate blood sugar levels and appetite. Health Canada said this generic, like existing products, is indicated to be used for the "once-weekly treatment of adult patients with Type 2 diabetes to manage blood sugar levels." With three generics on the market, Tadrous said the price could drop to about $100 or less, depending on their dose. Health Canada said it's currently reviewing eight other generic submissions by different companies and expects to make a decision on these in the next few weeks and months. https://www.cbc.ca/news/health/ozempic-generic-health-canada-9.7180566 XX  Insulet has enrolled the first participant in a pivotal study for its fully closed-loop (FCL)A automated insulin delivery (AID) system for type 2 diabetes (T2D  The participants are between 18 – 75 years of age, living with T2D and using insulin (basal-bolus or basal-only). The Company received Investigational Device Exemption (IDE) approval in March 2026 from the U.S. Food and Drug Administration (FDA). The Company plans to submit a 510(k) filing to the FDA in 2027 and launch its FCL AID system for T2D in 2028.   XX insulet Corporation (PODD) has initiated a voluntary recall of certain lots of its Omnipod 5 insulin delivery Pods in the U.S. after detecting that some devices had a manufacturing defect that causes insulin leakage.   Patients using the affected devices could risk experiencing high blood glucose levels due to insufficient insulin delivery, the Acton, Massachusetts-based MedTech disclosed in a statement late Thursday. The company has already notified the FDA about the recall, which it said will affect nearly 1.5% of Omnipod 5 pod units it manufactures annually. The customers were advised to immediately seek a product replacement at no cost if a Pod from a defective lot is currently in use. https://www.msn.com/en-us/money/companies/insulet-recalling-certain-defective-omnipod-insulin-delivery-devices/ar-AA1YyslT?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1&bundles=feat-es2020-c XX Tandem Diabetes Care (Nasdaq:TNDM) gets FDA clearance for its automated insulin delivery (AID) technology for use in pregnancy. The FDA cleared the company's Control-IQ AID technology for use in what they call: pregnancy complicated by type 1 diabetes mellitus. Tandem says t:slim X2 and Mobi are the first and only commercially available AID systems cleared for use during pregnancy in the U.S. https://www.drugdeliverybusiness.com/tandem-fda-clearance-aid-pregnancy-t1d/ XX Tandem also issued an urgent medical device correction for a software problem with its Mobi insulin pumps. The malfunction may cause insulin delivery to stop, causing high blood sugar if not addressed, the Food and Drug Administration said in a Wednesday recall notice. We told you about this back in October when Tandem sent a letter to customers notifying them of the fault and instructing them to update their pump software as soon as possible. The FDA now issued a class one recall, the most serious type. We just released a bonus episode all about Tanem – tubeless mobi and what else is in the pipeline. You can listen to that wherever you are listening to this.. it's the episode just before this one. https://www.medtechdive.com/news/tandem-recalls-mobi-insulin-pumps-over-software-malfunction/818260/   XX Switching CGMs didn't make a measurable difference for adults using MiniMed's pump system. In a real-world analysis presented at the International Conference on Advanced Technologies & Treatments for Diabetes, researchers found that CGM metrics for patients who switched from the Guardian 4 sensor (MiniMed) to Instinct by Abbott were able to maintain a time in range of greater than 75%. "When it comes to the automated insulin delivery system ... I think the sensor matters less and the system matters more," Viral N. Shah, MD, professor of medicine in the division of endocrinology and metabolism and director of diabetes clinical research at Indiana University Center for Diabetes and Metabolic Diseases, said during a presentation. "Having a different sensor with the system, I think the [glycemic] outcomes will still be what you want." I'm including this because the headline here seemed to indicate no CGM makes a difference, but this study only looked at two. https://www.healio.com/news/endocrinology/20260401/switching-cgm-sensors-does-not-impact-glycemic-outcomes-with-automated-insulin-delivery   XX Vitamin D supplementation may help delay or prevent disease progression in people with prediabetes.. in people who have specific variants in their vitamin D receptor gene. This was found after a second look at large study where researchers found vitamin d really did make a difference.. a second look with people who had a specific gene variation had much better results. "More research is needed to see if there are other factors that are associated with risk reduction." https://www.medicalnewstoday.com/articles/vitamin-d-supplements-help-prevent-type-2-diabetes-right-gene-variants   XX Senseonics (Nasdaq:SENS) announced today that it initiated the first European launch of its Eversense 365 continuous glucose monitor (CGM). The launch comes a few months after the company picked up CE mark for the long-term, implantable CGM in January. Eversense 365 is the world's first 365-day CGM system. It also holds clearance as an integrated CGM (iCGM) system, meaning it can work with compatible medical devices. Those include insulin pumps as part of automated insulin delivery systems, like the Sequel Med Tech twiist system. The company said it made Eversense 365 available to the first patients in Sweden. It plans to bring the sensor to Germany, Spain and Italy in the coming weeks https://www.drugdeliverybusiness.com/senseonics-launches-eversense-365-europe/ XX A machine learning model can improve genetic prediction of type 1 diabetes by as much as 10%, show results from a University of California, San Diego study.   The researchers used the machine‑learning model T1GRS to improve on a gold standard polygenic genetic risk score used to predict who is likely to develop the condition called GRS2. The GRS2 polygenic risk score has been widely tested and can be used to predict newborns who are at high risk of developing type 1 diabetes. While early prediction can't necessarily stop the disease it can help to prevent emergencies like diabetic ketoacidosis at diagnosis, allow families time to prepare and could allow use of therapies to delay onset of the condition. In this study, Gaulton and colleagues carried out a genome‑wide association study in 20,355 people with type 1 diabetes and 797,363 non‑diabetic Europeans, as well as a further analysis around the MHC region in 10,107 diabetic and 19,639 nondiabetic individuals. https://www.insideprecisionmedicine.com/topics/molecular-dx/machine-learning-tool-helps-improve-type-1-diabetes-prediction/ XX Sen. Mark Warner (D-Va.) said Monday that he will return to the upper chamber this week after taking time off for the death of his daughter, Madison.   The Virginia senator wrote on the social platform X, "As we remember our incredible daughter, Maddy, my family has been deeply touched by the outpouring of support we've received. Thank you to everyone for your kind words." Madison Warner, 36, died earlier this month after a decades-long battle with juvenile diabetes and other health issues. Mark Warner and his wife, Lisa Collis, wrote in a statement last Monday that they were "heartbroken beyond words" by their daughter's passing.   On Monday, the former Virginia governor said his daughter "was a deeply empathetic and engaged person" and that "as recently as the day she passed, she was full of ideas and suggestions" for him, including how he could improve his social media presence.   "She used to say to me: 'Dad, you have the power — you have to use it.' She pushed me to make the most of my position, to use my seat in the Senate to help people in meaningful ways," he added.       "If I can find any solace during this time, it's that I have the enormous privilege to serve Virginians and the responsibility to keep working for a better, more just world in Maddy's name."   Warner concluded, "I look forward to returning to the Senate this week and continuing that essential work."   Madison Warner is survived by two younger sisters.     An estimated than 2.1 million Americans, including about 314,000 children and adolescents younger than age 20, have diagnosed type 1 diabetes as of March — which is what juvenile diabetes is commonly called — according to the CDC's National Diabetes Statistics Report.   An estimated 11 million U.S. adults have undiagnosed diabetes, the report notes.   Symptoms of type 1 diabetes include feeling more thirsty than usual, urinating a lot, bed-wetting in children who have never done so, feeling very hungry and losing weight without trying, according to the Mayo Clinic. https://thehill.com/homenews/senate/5851605-mark-warner-diabetes-death/ XX Mattel, Inc. and Breakthrough T1D just won a Gold Halo Award for Best Cause Product Initiative for the launch of the first Barbie with T1D.  The Halo Awards recognize the most outstanding corporate social impact efforts over the past year.

Ever looked at your CGM arrows and thought… "okay but what does this actually mean?" In this episode, I'm breaking it all down in a simple, real-life way so you can stop guessing and start using your data with confidence. We'll go through flat, single, and double arrows - what they say about your blood sugar trends, how fast things are changing, and when you should (and shouldn't) react. I'll also cover the biggest mistakes people make, like overcorrecting or panicking, and how to use arrows alongside context (food, insulin, activity) to make smarter decisions. If you've been ignoring your arrows or stressing over them, this is your quick, no-BS guide to understanding CGM trends and staying in control.   Want the best blood sugars you've ever had while enjoying great food? Peep this: https://www.yourdiabetesinsider.com/coaching   RESOURCES: Download these FREE guides that will help you on your diabetes, nutrition, and exercise journey! https://www.yourdiabetesinsider.com/free-stuff LET'S TALK! Instagram: @yourdiabetesinsider Tiktok: @yourdiabetesinsider  

Book a free consultation call with Robert Sikes to break through your Keto or low carb plateau here: https://www.ketobodybuilding.com/callYour Garmin body battery is warning you about a massive health crash before it happens. In episode 884 of the Savage Perspective Podcast, host Robert Sikes and emergency room doctor Torkil Færø reveal the true science behind your fitness tracker. Most men ignore their resting heart rate and daily stress scores until they get sick. This talk shows how simple habits ruin your heart rate variability and keep your body in a state of panic. You will learn how late night snacks and poor sleep destroy your recovery time and lower your VO2 max. The doctor explains exactly how to use your wearable device to fix your metabolic health and lower your stress. Watch this full conversation to build a stronger body and find out what your tracking numbers actually mean.Follow Torkil on IG: https://www.instagram.com/dr.torkil/Get Keto Brick: https://www.ketobrick.com/Subscribe to the podcast: https://open.spotify.com/show/42cjJssghqD01bdWBxRYEg?si=1XYKmPXmR4eKw2O9gGCEuQChapters0:00 - Introduction: The Hidden Truth About ER Visits & Chronic Stress1:16 - Why Your Lifestyle is Ruining Your Health (And How Wearables Fix It)3:26 - The Biggest Health Mistake Doctors Make (A Physician's Wake-Up Call)7:31 - Why You Must Track Your Biometrics Before You Get Sick8:57 - Garmin vs. Oura Ring vs. Whoop: Which Fitness Tracker is Best?11:23 - Is Your Wearable Lying? The Truth About Sleep Tracking Accuracy13:03 - What is VO2 Max? The #1 Metric for Longevity & Mitochondrial Health16:07 - What is HRV? A Beginner's Guide to Heart Rate Variability & Stress20:43 - Stop Doing This! How Late-Night Eating Destroys Your HRV & Recovery22:54 - The Everyday Foods That Are Secretly Spiking Your Stress Levels26:33 - Should You Wear a CGM? Blood Sugar Spikes & Insulin Resistance Explained29:58 - The Shocking Impact of Nicotine Pouches & Stimulants on Your Heart33:37 - How to Balance Workouts & Recovery (The LeBron & Tom Brady Sleep Strategy)37:37 - Zone 2 Cardio vs. Max Effort: Understanding Wearable Recovery Scores40:51 - What is a Healthy Resting Heart Rate? (And Why Yours Might Be Too High)43:05 - Why the Modern Healthcare System is Broken (Be Proactive, Not Reactive)50:46 - Are Weight Loss Peptides (Ozempic/Wegovy) Actually Safe Long-Term?54:05 - The Pulse Cure: Mastering Your Garmin & Wearable Data

Book a free consultation call with Robert Sikes to break through your ketogenic or low carb plateau here: https://www.ketobodybuilding.com/call Eating only sardines for three weeks will completely rebuild your body from the inside out. In episode 880 of the Savage Perspective Podcast, host Robert Sikes and guest Jenny Mitich explore the true power of a sardine fast on the carnivore diet. They explain how meat heals your thyroid and calms Hashimoto's. You will learn how a hidden mold/toxic load stops fat loss and why strength training is so vital. They also show how to test your glucose/CGM and use a Keto Mojo or a continuous ketone monitor to track your ketones after eating keto snacks.Follow Jenny on IG: https://www.instagram.com/mamamitich/Get Keto Brick: https://www.ketobrick.com/Subscribe to the podcast: https://open.spotify.com/show/42cjJssghqD01bdWBxRYEg?si=1XYKmPXmR4eKw2O9gGCEuQChapters:0:00 - What Happens If You Eat Only Sardines for 21 Days? (Results + Reality)1:12 - How Do You Track a Sardine Fast Properly? (Blood Work, DEXA, CGM, Keto-Mojo)2:09 - Is a Sardine Fast Like an Egg Fast? (The “Food Noise” Reset Explained)3:40 - Is a 21-Day Sardine Fast Safe… or Too Much? (Who It's For + Smarter Alternatives)4:39 - What Are the Best Sardine Brands? (Cheap vs Premium + Butter-Canned Surprise)7:51 - Why Did She Start Carnivore? (Weight Loss, Glucose, Keto Flu, Family Buy-In)10:15 - What Should Kids Eat in a Carnivore Household? (Animal-Based Approach)10:49 - What Counts as “Carnivore”? (Spectrum, Dairy, Lion Diet, Meat + Fruit Debate)12:05 - Should You Track Calories/Macros on Carnivore? (Can You Gain Weight?)15:40 - Is Carnivore Bad for Female Hormones or Thyroid? (Hashimoto's Truth + Symptoms)18:58 - Are People Blaming Carnivore When They're Actually Undereating? (The Real Cause)20:46 - Can Mold and Toxic Load Wreck Thyroid Health? (Testing, Fatigue, Root Causes)23:47 - Do You Need Home Mold Remediation? (Environmental Test + Next Steps)24:50 - How Should Women Train for Muscle (Especially with Hashimoto's)? (Strength Focus)28:40 - Why Robert Doesn't Run Podcast Ads (And the Keto Bodybuilding Resource)30:40 - Parenting Reality: Are 4-Year-Olds Harder Than 3-Year-Olds?33:01 - Is Carnivore Growing or Peaking? (Trends, Dogma, and the Real Mission)36:31 - “Keto Kills” Headlines vs Ketogenic Research (Funding + Messaging)39:10 - Can Carnivore Help Anxiety and Mental Health? (Her Story + Why People Stay)42:15 - What's the Next Experiment? Do “Keto” Snacks Spike Glucose and Tank Ketones?45:54 - Meat Stock Plans + Her Book “Complete Carnivore” (What's Inside + Where to Buy)49:59 - Protein vs Fat on Carnivore: How Do You Troubleshoot Ketones? (Tracking Wins)54:18 - Are Continuous Ketone Monitors Worth It? (Sai Bio Accuracy + CGM Comparisons)57:10 - Where to Find Jenny Next (YouTube, New Cookbook, Conferences)

Scott and Jenny talk about how to bolus 4 ultra processed food.  Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED  or call 888-721-1514 ABLEnow save for today's needs or invest for tomorrow Tandem Mobi  Eversense CGM Medtronic Diabetes Touched By Type 1 Take the T1DExchange survey Type 1 Diabetes Pro Tips - THE PODCAST Use code JUICEBOX to save 20% at Cozy Earth  Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! * Omnipod Wilmot E, et al. Presented at: ATTD; March 19-22, 2025; Amsterdam, NL. A 13-week randomized, parallel-group clinical trial conducted among 188 participants (age 4-70) with type 1 diabetes in France, Belgium, and the U.K., comparing the safety and effectiveness of the Omnipod 5 System versus multiple daily injections with CGM. Among all paid Omnipod 5 G6G7 Pods Commercial and Medicare claims in 2024. Actual co-pay amount depends on patient's health plan and coverage, they may be higher or lower than the advertised amount. Source IQVIA OPC Library. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it.  

In this episode of Dishing Up Nutrition, Brandy talks with client Vanessa about her experience using a continuous glucose monitor (CGM) and what it revealed about her “healthy” habits. From afternoon crashes and cravings to better energy and mood, Vanessa shares how real-time blood sugar data helped her make simple, realistic changes to her diet, without giving up the things she loves. A great listen if you want practical insight into how food truly impacts how you feel.  

 Guest: Cynthia Thurlow, NP — Author of The Menopause Gut | 2x TEDx Speaker In this episode:How a Morocco trip landed Cynthia in the hospital for 13 days — and what God showed her thereWhy your gut is the key longevity organ you've never heard ofThe gut-brain, gut-bone, and gut-ovarian axes — how it's all connectedWhy "I go to the bathroom every day" doesn't mean your gut is healthyWhy digestion starts in the brain — not your stomachHow stress spikes your blood sugar more than food doesSkin rashes, brain fog, and psoriasis as gut signals — not separate problemsShort chain fatty acids, sodium butyrate, and rebuilding the microbiomeWhy postmenopausal women need to stop thinking about their hormones in silosCynthia's non-negotiables: sleep, boundaries, fiber, HRT, and no alcoholResources: Free Midlife Gut Guide → http://themenopausegut.com/midlife-gut-guide?am_id=tabatha7584 The Menopause Gut Book → https://themenopausegut.com/?am_id=tabatha3589 All-In-One Microbiome Lift → shop.fasttofaith.com/product/gut-lift/ Use code PODCAST for 20% off"I will restore your health and heal your wounds, declares the Lord." — Jeremiah 30:1700:00 — So many women have lost hope — give them some right now 00:58 — Welcome back: spring break, nature, and God's goodness 02:38 — Introducing Cynthia Thurlow: author, 2x TEDx speaker 04:11 — Pain to purpose: the theme of Fast to Faith guests 05:35 — Why women still don't know this information 06:36 — Cynthia's personal journey: how it all started 07:34 — Morocco, food poisoning, and 13 days in the hospital 12:54 — God is doing good works — are you getting on board? 15:35 — Giving women permission to advocate for themselves 15:45 — Omega Lift: why omega-3s matter more than ever 18:30 — How Cynthia healed: 9 months carnivore, 18 months to vegetables 22:04 — Why you can't eat fiber when your microbiome is decimated 23:19 — Carnivore as therapeutic — not forever 24:00 — Digestion is a north-to-south process — it starts in the brain 29:19 — Sodium butyrate and rebuilding the microbiome 30:51 — Gut health affects serotonin, GABA, and dopamine 31:52 — Your gut health determines your longevity 35:39 — Genesis, the microbiome, and how God designed us 36:39 — Skin rashes and psoriasis as gut signals 38:34 — Healthy Her: catching the signals before they become crises 39:35 — Healing takes years — not weeks 40:21 — Blood sugar, cortisol, and the CGM lesson 42:05 — It took time to learn these boundaries 42:19 — Cynthia's non-negotiables: sleep, stress, fiber, HRT, no alcohol 47:41 Ready to stop trying harder and start healing smarter? Start with the $5 Faith Reset Challenge — your first step to regulating your nervous system, stabilizing your metabolism, and reconnecting with your identity in Christ through simple, faith-centered rhythms. This is where most women begin. 

A $50 sensor on your arm, real-time data on your phone. The question isn't whether CGMs work. It's whether they're right for you. In this episode, Jeff takes a clear-eyed look at continuous glucose monitors. After wearing one revealed his own pre-diabetes, he spent years sorting the signal from the noise. Here's what CGMs show, what they miss, and who should actually use one. Inside the episode: How CGMs work, and why the 8 to 10% error margin matters Why your CGM is secretly one of the most honest stress monitors you can wear The glucose numbers worth knowing (and the ones to ignore) Why insulin resistance can precede a glucose spike by years The four CGM archetypes: Optimizer, Controller, Outsourcer, Curious Tourist The four biomarkers to check before you strap one on This episode is for anyone thinking about metabolic health, pre-diabetes, insulin resistance, or whether a continuous glucose monitor belongs on their arm. This episode was made possible by: Bon Charge: Get 15% off when you order at boncharge.com and use promo code COMMUNE LMNT: Get a free 8-count Sample Pack of LMNT's most popular drink mix flavors with any purchase at drinklmnt.com/commune. Vivobarefoot: Try Vivobarefoot risk-free with a 100-day return guarantee, and get 15% off your order at vivobarefoot.com/commune. Beyond Biohacking: Save $400 on any ticket with code COMMUNE400 at beyondconference.com. Sunlighten:  Visit sunlighten.com/commune  Up to 2,100 off saunas and $50 off Red Light Products with code “COMMUNE”

On April 3rd, in the middle of a regular workday, Lauren's CGM read 245 with double arrows up. She did not feel high. She bolused anyway. Twenty minutes later she was on her kitchen floor, chugging orange juice, with her blood sugar in the 30s, headed down fast. Her CGM had been over 100 points off.In this solo episode, Lauren shares exactly what happened that day, why it scared her in a way that CGM issues never had before, and what she believes needs to change in the conversation around CGM accuracy. She also talks about how to hold gratitude for the technology that keeps us alive while still being honest about its limitations and why trusting your instincts and finger pricking more often might be the most important PSA she can share right now.WHAT WE COVER:How Lauren's CGM was recently over 100 points off, and why it led to one of the worst lows she has had in yearsThe three issues she noticed immediately after switching to the Dexcom G7 last August and how they evolved over timeWhy she believes you can hold gratitude for diabetes technology in one hand and frustration in the other at the same timeWhat she would do differently next timeThe PSA every person with T1D needs to hear about finger pricking and what happens when you override your own instinctsWHAT'S NEXT:

Get ready to venture into the realm of cutting-edge health and nutrition as I reconnect with Kara Collier, a registered dietitian and the co-founder of Nutrisense, the revolutionary continuous glucose monitor app!  Our paths last crossed back in January of 2021, and I am thrilled to catch up with Kara again! Today, we delve deep into the ever-evolving landscape of metabolic health in 2023, exploring the pivotal role of CGM labs and glucometers in understanding our bodies.  In today's captivating conversation, Kara unravels the significance of measuring glucose against other metabolites, unveiling the profound impact of macros, exercise, supplements, sleep quality, life stage, and bio-individuality on our well-being. With a wealth of invaluable hacks to optimize your blood sugar, we invite you to join us on a captivating journey that will empower you to take charge of your health and transform your life!  Gear up for an enlightening conversation packed with valuable insights you will not want to miss! Prepare to be inspired and informed as we uncover the secrets to unlocking your metabolic potential! IN THIS EPISODE YOU WILL LEARN: The current state of metabolic health What is leading to obesity in the US? Getting your fasting glucose value below 90 The pros and cons of glucometers Glucose monitoring and the 8020 rule Tracking your data to learn about yourself Hacks to improve your diet The role of movement in metabolic health How important is Zone 2 training for mitochondrial health?  Follicular versus luteal phase and insulin sensitivity The importance of protein and carbohydrates Blood sugar and sleep quality About Kara: Kara Collier is the co-founder and VP of Health at Nutrisense, one of America's fastest-growing wellness-tech startups. After becoming frustrated with the shortcomings of the traditional healthcare system, she made it her mission to help others reach their maximum health potential using modern technology & expert coaching. She is the leading authority on the use of continuous glucose monitoring (CGM) technology for health optimization and disease prevention. Kara is a Registered Dietitian Nutritionist (RDN), Licensed Dietitian/Nutritionist (LDN), and Certified Nutrition Support Clinician (CNSC). Connect with Cynthia Thurlow Follow on X, Instagram & LinkedIn Check out Cynthia's website Submit your questions to support@cynthiathurlow.com Join other like-minded women in a supportive, nurturing community (The Midlife Pause/Cynthia Thurlow)  Cynthia's Menopause Gut Book is on presale now! Cynthia's Intermittent Fasting Transformation Book The Midlife Pause supplement line Connect with Kara Collier On ⁠Instagram⁠  ⁠Nutrisense⁠ ⁠Ep. 132 – Continuous Glucose Monitors: Why They're Not Just for Diabetics Anymore with Kara Collier

Julie, a pharmacist, diabetes educator, and mom, shares her son's diagnosis story and a candid conversation about type 1, type 2, food, movement, and real-world diabetes care. Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED  or call 888-721-1514 Tandem Mobi  ABLEnow save for today's needs or invest for tomorrow Eversense CGM Medtronic Diabetes Touched By Type 1 Take the T1DExchange survey Type 1 Diabetes Pro Tips - THE PODCAST Use code JUICEBOX to save 20% at Cozy Earth  Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! * Omnipod Wilmot E, et al. Presented at: ATTD; March 19-22, 2025; Amsterdam, NL. A 13-week randomized, parallel-group clinical trial conducted among 188 participants (age 4-70) with type 1 diabetes in France, Belgium, and the U.K., comparing the safety and effectiveness of the Omnipod 5 System versus multiple daily injections with CGM. Among all paid Omnipod 5 G6G7 Pods Commercial and Medicare claims in 2024. Actual co-pay amount depends on patient's health plan and coverage, they may be higher or lower than the advertised amount. Source IQVIA OPC Library. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!